Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q


☑			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended October 31, 2024


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from to

Commission File Number 1-14959

BRADY CORPORATION

(Exact name of registrant as specified in its charter)


Wisconsin						39-0178960
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

6555 West Good Hope Road

Milwaukee, Wisconsin 53223

(Address of principal executive offices and zip code)

(414) 358-6600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Class A Nonvoting Common Stock, par value $0.01 per share	BRC	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☑

Accelerated filer

☐

Emerging growth company

☐

Non-accelerated filer

☐

Smaller reporting company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

As of November 14, 2024, there were 44,223,720 outstanding shares of Class A Nonvoting Common Stock and 3,538,628 shares of Class B Voting Common Stock. The Class B Voting Common Stock, all of which is held by affiliates of the Registrant, is the only voting stock.

Table of Contents

INDEX



			Page
PART I. Financial Information			3
Item 1. Financial Statements (Unaudited)			3
Condensed Consolidated Balance Sheets			3
Condensed Consolidated Statements of Income			4
Condensed Consolidated Statements of Comprehensive Income			5
Condensed Consolidated Statements of Stockholders' Equity			6
Condensed Consolidated Statements of Cash Flows			7
Notes to Condensed Consolidated Financial Statements			8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			19
Item 3. Quantitative and Qualitative Disclosures About Market Risk			25
Item 4. Controls and Procedures			25
PART II. Other Information			26
Item 1. Legal Proceedings			26
Item 1A. Risk Factors			26
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			26
Item 5. Other Information			26
Item 6. Exhibits			27
Signatures			28

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in Thousands)


	October 31, 2024		July 31, 2024
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	145,661	$	250,118
Accounts receivable, net of allowance for credit losses of $10,295 and $6,749, respectively	218,258		185,486
Inventories	178,688		152,729
Prepaid expenses and other current assets	13,462		11,382
Total current assets	556,069		599,715
Property, plant and equipment—net	201,374		195,758
Goodwill	671,705		589,611
Other intangible assets	116,369		51,839
Deferred income taxes	16,841		15,596
Operating lease assets	42,157		38,504
Other assets	23,361		24,546
Total	$	1,627,876	$	1,515,569
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	98,179	$	84,691
Accrued compensation and benefits	65,004		77,954
Taxes, other than income taxes	22,901		14,061
Accrued income taxes	11,994		7,424
Current operating lease liabilities	13,120		13,382
Other current liabilities	90,272		67,170
Total current liabilities	301,470		264,682
Long-term debt	116,645		90,935
Long-term operating lease liabilities	29,201		25,342
Other liabilities	71,628		67,952
Total liabilities	518,944		448,911
Stockholders’ equity:
Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 44,223,664 and 44,042,462 shares, respectively	513		513
Class B voting common stock—Issued and outstanding, 3,538,628 shares	35		35
Additional paid-in capital	354,592		353,654
Retained earnings	1,209,406		1,174,025
Treasury stock—7,037,823 and 7,219,025 shares, respectively, of Class A nonvoting common stock, at cost	(344,012)		(351,947)
Accumulated other comprehensive loss	(111,602)		(109,622)
Total stockholders’ equity	1,108,932		1,066,658
Total	$	1,627,876	$	1,515,569

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Dollars in Thousands, Except Per Share Amounts, Unaudited)


	Three months ended October 31,
	2024		2023
Net sales	$	377,065	$	331,983
Cost of goods sold	187,376		160,264
Gross margin	189,689		171,719
Operating expenses:
Research and development	18,921		15,702
Selling, general and administrative	111,846		96,287
Total operating expenses	130,767		111,989
Operating income	58,922		59,730
Other income (expense):
Investment and other income	1,234		438
Interest expense	(1,356)		(766)
Income before income taxes	58,800		59,402
Income tax expense	12,017		12,161
Net income	$	46,783	$	47,241
Net income per Class A Nonvoting Common Share:
Basic	$	0.98	$	0.97
Diluted	$	0.97	$	0.97
Net income per Class B Voting Common Share:
Basic	$	0.96	$	0.96
Diluted	$	0.95	$	0.95
Weighted average common shares outstanding:
Basic	47,732		48,505
Diluted	48,217		48,811

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Dollars in Thousands, Unaudited)


	Three months ended October 31,
	2024		2023
Net income	$	46,783	$	47,241
Other comprehensive loss:
Foreign currency translation adjustments	(79)		(20,364)

Cash flow hedges:
Net loss recognized in other comprehensive loss	(1,338)		(294)
Reclassification adjustment for gains included in net income	(464)		(1,285)
	(1,802)		(1,579)

Pension and other post-retirement benefits actuarial gain amortization	(151)		(151)

Other comprehensive loss, before tax	(2,032)		(22,094)
Income tax benefit (expense) related to items of other comprehensive loss	52		(128)
Other comprehensive loss, net of tax	(1,980)		(22,222)
Comprehensive income	$	44,803	$	25,019

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(Dollars in Thousands, Unaudited)


	Three months ended October 31, 2024
	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity
Balances at July 31, 2024	$	548	$	353,654	$	1,174,025	$	(351,947)	$	(109,622)	$	1,066,658
Net income	—		—		46,783		—		—		46,783
Other comprehensive loss, net of tax	—		—		—		—		(1,980)		(1,980)
Issuance of shares of Class A Common Stock under stock plan	—		(5,065)		—		7,935		—		2,870
Tax benefit and withholdings from deferred compensation distributions	—		190		—		—		—		190
Stock-based compensation expense	—		5,813		—		—		—		5,813

Cash dividends on Common Stock:
Class A — $0.2400 per share	—		—		(10,612)		—		—		(10,612)
Class B — $0.2234 per share	—		—		(790)		—		—		(790)
Balances at October 31, 2024	$	548	$	354,592	$	1,209,406	$	(344,012)	$	(111,602)	$	1,108,932


	Three months ended October 31, 2023
	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity
Balances at July 31, 2023	$	548	$	351,771	$	1,021,870	$	(290,209)	$	(93,061)	$	990,919
Net income	—		—		47,241		—		—		47,241
Other comprehensive loss, net of tax	—		—		—		—		(22,222)		(22,222)
Issuance of shares of Class A Common Stock under stock plan	—		(3,662)		—		3,927		—		265
Tax benefit and withholdings from deferred compensation distributions	—		149		—		—		—		149
Stock-based compensation expense	—		4,163		—		—		—		4,163
Repurchase of shares of Class A Common Stock, including excise taxes	—		—		—		(14,185)		—		(14,185)
Cash dividends on Common Stock:
Class A — $0.2350 per share	—		—		(10,565)		—		—		(10,565)
Class B — $0.2184 per share	—		—		(773)		—		—		(773)
Balances at October 31, 2023	$	548	$	352,421	$	1,057,773	$	(300,467)	$	(115,283)	$	994,992

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in Thousands, Unaudited)


	Three months ended October 31,
	2024		2023
Operating activities:
Net income	$	46,783	$	47,241
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	10,164		7,466
Stock-based compensation expense	5,813		4,163
Deferred income taxes	(903)		(2,225)
Other	(880)		1,137
Changes in operating assets and liabilities:
Accounts receivable	(4,385)		(2,205)
Inventories	(2,107)		6,152
Prepaid expenses and other assets	(1,136)		(1,488)
Accounts payable and accrued liabilities	(33,960)		(3,725)
Income taxes	4,017		5,757
Net cash provided by operating activities	23,406		62,273

Investing activities:
Purchases of property, plant and equipment	(7,286)		(11,279)
Acquisition of businesses, net of cash acquired	(140,625)		—
Other	10		—
Net cash used in investing activities	(147,901)		(11,279)

Financing activities:
Payment of dividends	(11,402)		(11,338)
Proceeds from exercise of stock options	5,855		2,598
Payments for employee taxes withheld from stock-based awards	(2,090)		(2,333)
Purchase of treasury stock	—		(14,121)
Proceeds from borrowing on credit agreement	135,149		38,551
Repayment of borrowing on credit agreement	(109,439)		(36,000)
Other	190		1,149
Net cash provided by (used in) financing activities	18,263		(21,494)

Effect of exchange rate changes on cash and cash equivalents	1,775		(5,680)

Net (decrease) increase in cash and cash equivalents	(104,457)		23,820
Cash and cash equivalents, beginning of period	250,118		151,532
Cash and cash equivalents, end of period	$	145,661	$	175,352

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Three Months Ended October 31, 2024

(Unaudited)

(In thousands, except share and per share amounts)

NOTE A — Basis of Presentation

The condensed consolidated financial statements included herein have been prepared by Brady Corporation and subsidiaries (the “Company,” “Brady,” “we,” or “our”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of the Company, the foregoing statements contain all adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial position of the Company as of October 31, 2024 and July 31, 2024, its results of operations, cash flows and comprehensive income for the three months ended October 31, 2024 and 2023. The condensed consolidated balance sheet as of July 31, 2024 has been derived from the audited consolidated financial statements as of that date. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts therein. Due to the inherent uncertainty involved in making estimates, actual results in future periods may differ from the estimates.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to rules and regulations of the Securities and Exchange Commission. Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statement presentation. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended July 31, 2024.

NOTE B — New Accounting Pronouncements

Standards not yet adopted

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The guidance requires expanded interim and annual disclosures of segment information including the disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within segment profit and loss. The guidance is effective for the Company's fiscal 2025 Form 10-K and interim periods thereafter. The Company is currently assessing its segment information disclosures in connection with the adoption of ASU 2023-07.

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” The guidance requires expanded annual disclosures including the standardization and disaggregation of income tax rate reconciliation categories and the amount of income taxes paid by jurisdiction. The guidance is effective for the Company’s fiscal 2026 Form 10-K. The Company is currently assessing its income tax disclosures in connection with the adoption of ASU 2023-09.

In November 2024, the FASB issued ASU 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” The guidance requires expanded interim and annual disclosures of expense information including the amounts of inventory purchases, employee compensation, depreciation, amortization, and depletion within commonly presented expense captions during the period. The guidance is effective for the Company's fiscal 2028 Form 10-K and interim periods thereafter. The Company is currently evaluating the ASU to determine its impact on the Company's disclosures.

Table of Contents

NOTE C — Additional Balance Sheet Information

Inventories

Inventories consisted of the following as of October 31, 2024 and July 31, 2024:


	October 31, 2024		July 31, 2024
Finished products	$	103,375	$	89,430
Work-in-process	27,029		24,601
Raw materials and supplies	48,284		38,698
Total inventories	$	178,688	$	152,729

Property, plant and equipment

Property, plant and equipment is presented net of accumulated depreciation in the amount of $308,128 and $304,199 as of October 31, 2024 and July 31, 2024, respectively.

NOTE D — Other Intangible Assets

Other intangible assets as of October 31, 2024 and July 31, 2024 consisted of the following:


	October 31, 2024							July 31, 2024
	Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value
Amortized other intangible assets:
Tradenames	2	$	868	$	(108)	$	760	3	$	600	$	(600)	$	—
Customer relationships	8	122,289		(26,899)		95,390		9	64,430		(23,279)		41,151
Technology	5	19,857		(7,215)		12,642		5	9,300		(6,182)		3,118
Unamortized other intangible assets:
Tradenames	N/A	7,577		—		7,577		N/A	7,570		—		7,570
Total		$	150,591	$	(34,222)	$	116,369		$	81,900	$	(30,061)	$	51,839

The change in the gross carrying amount of other intangible assets as of October 31, 2024 compared to July 31, 2024 was primarily due to the acquisitions of Gravotech Holding (“Gravotech”) and American Barcode and RFID Incorporated (“AB&R”) completed during the three months ended October 31, 2024 and to a lesser extent, the effect of currency fluctuations. Refer to Note O, “Acquisitions,” for additional information on intangible assets acquired.

Amortization expense on intangible assets was $4,713 and $2,355 for the three months ended October 31, 2024 and 2023, respectively.

NOTE E — Leases

The Company leases certain manufacturing facilities, warehouse and office spaces, and vehicles accounted for as operating leases. Lease terms typically range from one year to ten years. As of October 31, 2024, the Company did not have any finance leases.

Operating lease expense was $4,735 and $4,065 for the three months ended October 31, 2024 and 2023, respectively, which was recognized in either “Cost of goods sold” or “Selling, general and administrative” expenses in the condensed consolidated statements of income based on the nature of the lease. Short-term lease expense, variable lease expenses, and sublease income were immaterial to the condensed consolidated statements of income for the three months ended October 31, 2024 and 2023.

Table of Contents

Supplemental cash flow information related to the Company's operating leases for the three months ended October 31, 2024 and 2023 was as follows:


	Three months ended October 31,
	2024		2023
Operating cash flows from operating leases	$	4,619	$	4,431
Operating lease assets obtained in exchange for new operating lease liabilities (1)	7,630		1,656

(1) Includes new leases, acquired leases and remeasurements or modifications of existing leases.

NOTE F — Accumulated Other Comprehensive Loss

Other comprehensive loss consists of foreign currency translation adjustments which includes net investment hedges and long-term intercompany loan translation adjustments, unrealized gains from cash flow hedges and the unamortized gain on post-retirement plans, net of their related tax effects.

The following table illustrates the changes in the balances of each component of accumulated other comprehensive loss, net of tax, for the three months ended October 31, 2024:


	Unrealized loss on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2024	$	(149)	$	462	$	(109,935)	$	(109,622)
Other comprehensive loss before reclassification	(1,402)		—		(79)		(1,481)
Amounts reclassified from accumulated other comprehensive loss	(348)		(151)		—		(499)
Ending balance, October 31, 2024	$	(1,899)	$	311	$	(110,014)	$	(111,602)

The increase in accumulated other comprehensive loss as of October 31, 2024 compared to July 31, 2024 was primarily due to the unrealized losses on cash flow hedges during the three-month period.

The changes in accumulated other comprehensive loss by component, net of tax, for the three months ended October 31, 2023 were as follows:


	Unrealized gain (loss) on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2023	$	1,641	$	756	$	(95,458)	$	(93,061)
Other comprehensive loss before reclassification	(744)		—		(20,364)		(21,108)
Amounts reclassified from accumulated other comprehensive loss	(963)		(151)		—		(1,114)
Ending balance, October 31, 2023	$	(66)	$	605	$	(115,822)	$	(115,283)

The increase in the accumulated other comprehensive loss as of October 31, 2023 compared to July 31, 2023 was primarily due to the appreciation of the U.S. dollar against certain other currencies during the three-month period.

Of the amounts reclassified from accumulated other comprehensive loss during the three months ended October 31, 2024 and 2023, unrealized gains on cash flow hedges were reclassified to “Cost of goods sold” and unamortized gains on post-retirement plans were reclassified into “Investment and other income” on the condensed consolidated statements of income.

The following table illustrates the income tax benefit (expense) on the components of other comprehensive loss for the three months ended October 31, 2024 and 2023:


	Three months ended October 31,
	2024		2023
Income tax benefit (expense) related to items of other comprehensive loss:
Cash flow hedges	$	52	$	(128)

Table of Contents

NOTE G — Revenue Recognition

The Company recognizes revenue when control of the product or service transfers to the customer at an amount that represents the consideration expected to be received in exchange for those products and services. The Company’s revenues are primarily from the sale of identification solutions and workplace safety products that are shipped and billed to customers. All revenue is from contracts with customers and is included in “Net sales” on the condensed consolidated statements of income. See Note H, “Segment Information,” for the Company’s disaggregated revenue disclosure.

The Company offers extended warranty coverage that is included in the sales price of certain products, which it accounts for as service warranties. The Company accounts for the deferred revenue associated with extended service warranties as a contract liability. The balance of contract liabilities associated with service warranty performance obligations was $2,973 and $2,947 as of October 31, 2024 and July 31, 2024, respectively. The current portion and non-current portion of contract liabilities are included in “Other current liabilities” and “Other liabilities,” respectively, on the condensed consolidated balance sheets. The Company recognized revenue of $337 and $314 during the three months ended October 31, 2024 and 2023, respectively, that was included in the contract liability balance at the beginning of the respective period from the amortization of extended service warranties. Of the contract liability balance outstanding at October 31, 2024, the Company expects to recognize 32% by the end of fiscal 2025, an additional 31% by the end of fiscal 2026, and the remaining balance thereafter.

NOTE H — Segment Information

The Company is organized and managed within two regions: Americas & Asia and Europe & Australia, which are the reportable segments.

The following is a summary of net sales by segment and geographic region for the three months ended October 31, 2024 and 2023:


	Three months ended October 31,
	2024		2023
Net sales:
Americas & Asia
Americas	$	214,033	$	196,286
Asia	31,395		25,340
Total	$	245,428	$	221,626
Europe & Australia
Europe	116,153		96,333
Australia	15,484		14,024
Total	$	131,637	$	110,357

Total Company	$	377,065	$	331,983

The following is a summary of segment profit for the three months ended October 31, 2024 and 2023:


	Three months ended October 31,
	2024		2023
Segment profit:
Americas & Asia	$	54,900	$	49,897
Europe & Australia	13,114		16,744
Total Company	$	68,014	$	66,641

Table of Contents

The following is a reconciliation of segment profit to income before income taxes for the three months ended October 31, 2024 and 2023:


	Three months ended October 31,
	2024		2023
Total profit from reportable segments	$	68,014	$	66,641
Unallocated amounts:
Administrative costs	(9,092)		(6,911)
Investment and other income	1,234		438
Interest expense	(1,356)		(766)
Income before income taxes	$	58,800	$	59,402

NOTE I – Stock-Based Compensation

Incentive Stock Plans

The Company has an incentive stock plan under which the Board of Directors may grant nonqualified stock options to purchase shares of Class A Nonvoting Common Stock, restricted stock units (“RSUs”), performance-based restricted stock units (“PRSUs”), or restricted and unrestricted shares of Class A Nonvoting Common Stock to employees and non-employee directors. Certain awards may be subject to pre-established performance goals. The majority of the Company’s annual share-based awards are granted in the first quarter of the fiscal year.

Total stock-based compensation expense recognized during the three months ended October 31, 2024 and 2023 was $5,813 and $4,163, respectively. The total income tax benefit recognized in the condensed consolidated statements of income was $632 and $425 during the three months ended October 31, 2024 and 2023, respectively.

Stock Options

The stock options issued under the plan have an exercise price equal to the market price of the Company's stock at the date of the grant and generally vest ratably over three years, with one-third becoming exercisable one year after the grant date and one-third additional in each of the succeeding two years. Options issued under the plan, referred to herein as “time-based” options, generally expire ten years from the date of grant. The Company did not include stock options in its annual grant of share-based awards to employees in the current fiscal year.

The following is a summary of stock option activity for the three months ended October 31, 2024:


Time-Based Options	Options Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at July 31, 2024	1,222,046	$	44.46
Granted	—	—
Exercised	(128,803)	38.83
Forfeited	(1,720)	50.19
Outstanding at October 31, 2024	1,091,523	$	45.12	5.4	$	28,592
Exercisable at October 31, 2024	1,010,597	$	44.84	5.2	$	26,754

The following table summarizes additional stock option information:


	Three months ended October 31,
	2024		2023

Intrinsic value of options exercised during the period (in thousands)	$	4,622	$	3,410
Fair value of options vested during the period (in thousands)	1,249		1,729
Cash received from the exercise of stock options during the period (in thousands)	5,855		2,598
Tax benefit on options exercised during the period (in thousands)	1,112		841

As of October 31, 2024, total unrecognized compensation cost related to stock options was $674 pre-tax, net of estimated forfeitures, which the Company expects to recognize over a weighted-average period of 1.5 years.

Table of Contents

RSUs

RSUs issued under the plan have a grant date fair value equal to the market price of the Company's stock at the date of grant and generally vest ratably over three years, with one-third vesting one year after the grant date and an additional one-third in each of the succeeding two years.

The following is a summary of RSU activity for the three months ended October 31, 2024:


	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested RSUs as of July 31, 2024	148,991	$	52.20
Granted	88,319	74.63
Vested	(56,393)	51.07
Forfeited	(763)	58.94
Non-vested RSUs as of October 31, 2024	180,154	$	63.53

The RSUs granted during the three months ended October 31, 2023 had a weighted-average grant date fair value of $54.80. The total fair value of RSUs vested during the three months ended October 31, 2024 and 2023 was $4,201 and $2,974, respectively.

As of October 31, 2024, total unrecognized compensation cost related to RSUs was $6,090 pre-tax, net of estimated forfeitures, which the Company expects to recognize over a weighted-average period of 2.4 years.

PRSUs

PRSUs are contingent on the achievement of predetermined market and performance targets. The PRSUs granted under the plan vest at the end of a three-year performance period provided the service period and specified performance targets are met. For the PRSUs granted during the three months ended October 31, 2024 and 2023, awards will vest based on achievement of performance conditions relating to Company revenue and diluted EPS targets. For the PRSUs granted during the three months ended October 31, 2022, the vesting criteria for 50% of the grant is based upon the Company's total shareholder return (“TSR”) relative to the S&P 600 SmallCap Industrials Index over a three-year performance period, and the vesting criteria for the other 50% of the grant is based upon Company revenue targets.

The PRSUs granted during the three months ended October 31, 2024 had a fair value determined by the average of the high and low stock price on the date of the grant. For awards with a market value condition, a third-party valuation is utilized to determine the fair value as of the grant date using a Monte Carlo simulation for that portion of the award.

The following is a summary of PRSU activity for the three months ended October 31, 2024:


	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested PRSUs as of July 31, 2024	103,221	$	53.46
Granted	61,981	71.24
Vested	(8,098)	64.44
Forfeited	(2,157)	55.23
Non-vested PRSUs as of October 31, 2024	154,947	$	59.95

The PRSUs granted during the three months ended October 31, 2023 had a weighted-average grant date fair value of $51.16. The total fair value of PRSUs vested during the three months ended October 31, 2024 and 2023 was $595 and $141, respectively.

As of October 31, 2024, total unrecognized compensation cost related to PRSUs was $6,812 pre-tax, net of estimated forfeitures, which the Company expects to recognize over a weighted-average period of 2.3 years.

Table of Contents

NOTE J — Net Income per Common Share

Reconciliations of the numerator and denominator of the basic and diluted per share computations for the Company’s Class A and Class B common stock are summarized as follows:


	Three months ended October 31,
	2024		2023
Numerator (in thousands):
Net income (Numerator for basic and diluted income per Class A Nonvoting Common Share)	$	46,783	$	47,241
Less:
Preferential dividends	(736)		(748)
Preferential dividends on dilutive stock options	(8)		(5)
Numerator for basic and diluted income per Class B Voting Common Share	$	46,039	$	46,488
Denominator (in thousands):
Denominator for basic income per share for both Class A and Class B	47,732		48,505
Plus: Effect of dilutive equity awards	485		306
Denominator for diluted income per share for both Class A and Class B	48,217		48,811
Net income per Class A Nonvoting Common Share:
Basic	$	0.98	$	0.97
Diluted	$	0.97	$	0.97
Net income per Class B Voting Common Share:
Basic	$	0.96	$	0.96
Diluted	$	0.95	$	0.95

Potentially dilutive securities attributable to outstanding stock options and restricted stock units were excluded from the calculation of diluted earnings per share where the combined exercise price and average unamortized fair value were greater than the average market price of the Company's Class A Nonvoting Common Stock because the effect would have been anti-dilutive. The amount of anti-dilutive shares were 17,278 and 313,787 for the three months ended October 31, 2024 and 2023, respectively.

NOTE K — Fair Value Measurements

In accordance with fair value accounting guidance, the Company determines fair value based on the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The inputs used to measure fair value are classified into the following hierarchy:

Level 1 — Unadjusted quoted prices in active markets for identical instruments that are accessible as of the reporting date.

Level 2 — Other significant pricing inputs that are either directly or indirectly observable.

Level 3 — Significant unobservable pricing inputs, which result in the use of management's own assumptions.

The following table summarizes the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis at October 31, 2024 and July 31, 2024:


	October 31, 2024		July 31, 2024		Fair Value Hierarchy
Assets:
Deferred compensation plan assets	$	18,180	$	20,029	Level 1
Foreign exchange contracts	148		137		Level 2
Liabilities:
Foreign exchange contracts	1,614		730		Level 2

The following methods and assumptions were used to estimate the fair value of each class of financial instrument:

Deferred compensation plan assets: The Company’s deferred compensation investments consist of investments in mutual funds, which are included in “Other assets” on the condensed consolidated balance sheets. These investments were classified as Level 1 as the shares of these investments trade with sufficient frequency and volume to enable us to obtain pricing information on an ongoing basis.

Table of Contents

Foreign exchange contracts: The Company’s foreign exchange contracts were classified as Level 2 as the fair value was based on the present value of the future cash flows using external models that use observable inputs, such as interest rates, yield curves and foreign exchange rates. See Note L, “Derivatives and Hedging Activities,” for additional information.

The fair values of cash and cash equivalents, accounts receivable, accounts payable, and other liabilities approximated carrying values due to their short-term nature.

NOTE L — Derivatives and Hedging Activities

The Company utilizes forward foreign exchange currency contracts to reduce the exchange rate risk of specific foreign currency denominated transactions. These contracts typically require the exchange of a foreign currency for U.S. dollars at a fixed rate on a future date, with maturities of less than 18 months, which qualify as cash flow hedges or net investment hedges under the accounting guidance for derivative instruments and hedging activities. The primary objective of the Company’s foreign currency exchange risk management program is to minimize the impact of currency movements due to transactions in other than the respective subsidiaries’ functional currency and to minimize the impact of currency movements on the Company’s net investment denominated in a currency other than the U.S. dollar. To achieve this objective, the Company hedges a portion of known exposures using forward foreign exchange currency contracts.

Main foreign currency exposures are related to transactions denominated in the British Pound, Euro, Canadian dollar, Australian dollar, Mexican Peso, Chinese Yuan, Malaysian Ringgit and Singapore dollar. Generally, these risk management transactions will involve the use of foreign currency derivatives to minimize the impact of currency movements on non-functional currency transactions.

The U.S. dollar equivalent notional amounts of outstanding forward exchange contracts were as follows:


	October 31, 2024		July 31, 2024
Designated as cash flow hedges	$	44,448	$	59,207
Non-designated hedges	4,171		4,459
Total foreign exchange contracts	$	48,619	$	63,666

Cash Flow Hedges

The Company has designated a portion of its forward foreign exchange contracts as cash flow hedges and recorded these contracts at fair value on the condensed consolidated balance sheets. For these instruments, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income (“OCI”) and reclassified into income in the same period or periods during which the hedged transaction affects income. As of October 31, 2024 and July 31, 2024, unrealized losses of $1,926 and $124 have been included in OCI, respectively.

Net Investment Hedges

The Company has designated certain third party foreign currency denominated debt borrowed under its credit agreement as net investment hedges. These debt obligations, denominated in Euros and British Pounds, were designated as net investment hedges to hedge portions of the Company's net investment in its European operations. The Company’s foreign currency denominated debt obligations are valued under a market approach using publicized spot prices, and the net gains or losses attributable to the changes in spot prices are recorded as cumulative translation within AOCI and are included in the foreign currency translation adjustments section of the condensed consolidated statements of comprehensive income. As of October 31, 2024 and July 31, 2024, the cumulative balance recognized in accumulated other comprehensive income were losses of $1,427 and $1,237, respectively, on any outstanding foreign currency denominated debt obligations.

Table of Contents

The following table summarizes the amount of pre-tax gains and losses related to derivatives designated as hedging instruments:


	Three months ended October 31,
	2024		2023
(Losses) gains recognized in OCI:
Forward exchange contracts (cash flow hedges)	$	(1,338)	$	(294)
Foreign currency denominated debt (net investment hedges)	(190)		1,508
Gains reclassified from OCI into cost of goods sold:
Forward exchange contracts (cash flow hedges)	464		1,285

Fair values of derivative instruments in the condensed consolidated balance sheets were as follows:


	October 31, 2024						July 31, 2024
	Prepaid expenses and other current assets		Other current liabilities		Long-term Obligations		Prepaid expenses and other current assets		Other current liabilities		Long-term Obligations
Derivatives designated as hedging instruments:
Foreign exchange contracts (cash flow hedges)	$	148	$	1,610	$	—	$	137	$	726	$	—
Foreign currency denominated debt (net investment hedges)	—		—		34,251		—		—		34,060
Derivatives not designated as hedging instruments:
Foreign exchange contracts (non-designated hedges)	—		4		—		—		4		—
Total derivative instruments	$	148	$	1,614	$	34,251	$	137	$	730	$	34,060

NOTE M – Income Taxes

The income tax rate for the three months ended October 31, 2024 and 2023 was 20.4% and 20.5%, respectively.

NOTE N — Contingencies

In the normal course of business, the Company is subject to a variety of investigations, claims, suits, and other legal proceedings, including but not limited to, intellectual property, employment, unclaimed property, tort, and breach of contract matters. Any legal proceedings are subject to inherent uncertainties, and these matters and their potential effects may change in the future. The Company records a liability for contingencies when a loss is deemed to be probable and the loss can be reasonably estimated. The Company currently believes that the outcomes of such proceedings will not have a material adverse impact on its business, financial position, results of operations or cash flows.

NOTE O — Acquisitions

On August 1, 2024, the Company acquired all of the outstanding shares of Gravotech. Headquartered in Lyon, France, Gravotech is a leader in the design, manufacture and distribution of innovative solutions for specialized engraving, marking and cutting, offering laser, mechanical engraving, scribing and dot peen capabilities across multiple industries. The acquisition of Gravotech expands the Company’s identification product offerings and research and development capabilities to include specialized direct part marking and engraving expertise. The acquisition was funded through cash on hand and borrowings under the Company’s existing credit agreement. Net sales and net loss attributable to Gravotech from the acquisition date through October 31, 2024 were $29,475 and $4,685, respectively. The net loss attributable to Gravotech is due to a nonrecurring increase in cost of goods sold of $4,115 related to the fair value adjustment to inventory upon acquisition and amortization expense of $2,326 for intangible assets acquired.

The Company recorded its preliminary purchase price allocation during the three months ended October 31, 2024, based on its estimates of the fair value of the acquired assets and assumed liabilities as of the acquisition date. The preliminary purchase price allocation included goodwill of $71,790, of which $49,874 was assigned to the Americas & Asia segment and $21,916 was assigned to the Europe & Australia segment.

Table of Contents

The following table summarizes the preliminary fair value of the assets acquired and liabilities assumed at the date of the acquisition:


Cash and cash equivalents	$	7,667
Accounts receivable, net	24,325
Inventories	21,751
Prepaid expenses and other current assets	563
Property, plant and equipment — net	2,538
Goodwill	71,790
Other intangible assets	65,798
Operating lease assets	6,981
Other assets	1,061
Accounts payable	(17,813)
Accrued compensation and benefits	(9,347)
Taxes, other than income taxes	(6,857)
Accrued income taxes	(1,855)
Other current liabilities	(18,157)
Operating lease liabilities	(6,980)
Other liabilities	(6,908)
Net assets acquired	$	134,557
Less: cash acquired	(7,667)

Fair value of total consideration	$	126,890

The final purchase price allocation is subject to post-closing adjustments pursuant to the terms of the securities sale and purchase agreement, as well as the finalization of certain accounts, primarily intangible assets and deferred tax adjustments. The goodwill for this acquisition is not deductible for tax purposes.

The following table presents the unaudited pro forma operating results for the three months ended October 31, 2024 and 2023, reflecting the acquisition of Gravotech as if it had occurred at the beginning of fiscal year 2024. The unaudited pro forma operating results for the three months ended October 31, 2024 do not contain any adjustments to the accompanying condensed consolidated financial statements. The unaudited pro forma operating results for the three months ended October 31, 2023 include Gravotech’s normal operating results and pro forma adjustments to include cumulative expenses, net of tax, for the nonrecurring fair value adjustment to inventory, amortization expense for acquired intangible assets and interest expense on acquisition-related debt. The unaudited pro forma operating results are presented for comparative purposes only and do not necessarily reflect future operating results or those that would have occurred had the acquisition been completed at the beginning of fiscal year 2024.


	Three months ended October 31,
	2024		2023
Net sales, pro forma	$	377,065	$	361,109
Net income, pro forma	46,783		43,535

Table of Contents

On October 1, 2024, the Company acquired all of the outstanding shares of AB&R for $15,625, net of cash acquired. Based in Phoenix, Arizona, AB&R provides integrated solutions for asset tracking, inventory management, and workflow optimization using advanced identification and tracking technologies, including barcoding, radio frequency identification (“RFID”) and Internet of Things (“IoT”)-based systems. The acquisition was funded through cash on hand and borrowings under the Company’s existing credit agreement. The Company recorded its preliminary purchase price allocation during the first quarter of fiscal year 2025, based on its estimates of the fair value of the acquired assets and assumed liabilities at that time. The preliminary purchase price allocation included goodwill of $10,877, intangible assets of $4,600, and net tangible assets of $148. The goodwill for this acquisition is assigned to the Americas & Asia segment and is deductible for tax purposes. The final purchase price allocation is subject to post-closing adjustments and the finalization of certain intangible asset valuations and deferred tax adjustments, as well as potential contingent consideration subject to AB&R’s achievement of certain post-acquisition financial targets pursuant to the terms of the membership interest purchase agreement. Acquisition-related expenses of $305 were recognized in selling, general and administrative (“SG&A”) expenses during the three months ended October 31, 2024. The accompanying condensed consolidated financial statements include the results of AB&R from the date of acquisition through October 31, 2024. Pro forma and other financial information are not presented for the AB&R acquisition because its impact on the Company's results of operation and financial position is immaterial.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Brady Corporation is a global manufacturer and supplier of identification solutions and workplace safety products that identify and protect premises, products and people. The Company is organized and managed on a geographic basis with two reportable segments: Americas & Asia and Europe & Australia. This regional operating structure allows the Company to further integrate its businesses, support continued growth through the application of the best go-to-market strategies in key geographies, facilitate new product development within recent acquisitions and further simplify and scale the global business.

Within each of the reportable segments, the Company markets, sells and distributes a broad range of identification and safety products and solutions across the following primary product categories:

•Safety and facility identification and protection, which includes safety signs, traffic signs and control products, floor-marking tape, pipe markers, labeling systems, spill control products, lockout/tagout devices, personal protection equipment, first aid products, and software and services for safety compliance auditing, procedures writing and training.

•Product identification, which includes materials, printing systems, radio frequency identification (“RFID”) and barcode scanners for product identification, engraving equipment, brand protection labeling, work in process labeling, finished product identification, asset tracking labels, asset tags and industrial track and trace applications.

•Wire identification, which includes handheld printers, wire markers, sleeves, and tags.

•Healthcare identification, which includes wristbands, labels, printing systems, and other products used in hospital, laboratory, and other healthcare settings for tracking and improving the safety of patients.

•People identification, which includes name tags, badges, lanyards, rigid card printing systems, and access control software.

The ability to provide customers with a broad range of proprietary, customized and diverse products for use in various applications across multiple industries and geographies, along with a commitment to quality and service, have made Brady a leader in many of its markets. Brady's long-term sales growth and profitability will depend not only on the overall economic environment and our ability to successfully navigate changes in the macro environment, but also on our ability to develop and market innovative products, deliver a high level of customer service, advance our digital capabilities, and continuously improve the efficiency of our global operations. Our strategy for growth includes an increased focus on certain industries and products, streamlining our product offerings, expanding into higher growth end-markets, improving the overall customer experience, developing technologically advanced, innovative, and proprietary products, and improving our digital capabilities.

The following are key initiatives supporting our strategy in fiscal 2025:

•Investing in organic growth by enhancing our research and development process and utilizing customer feedback and observations to develop innovative new products that solve customer needs and improve environmental sustainability.

•Providing the highest level of customer service by aligning with customers' preferred communications channels and leveraging technology to enhance the customer experience.

•Expanding and enhancing our sales capabilities through an improved digital presence and the use of data-driven marketing automation tools.

•Maintaining profitability through pricing mechanisms to mitigate the impacts of ongoing supply chain disruptions and inflationary pressures while ensuring prices are market competitive.

•Integrating recent acquisitions to further enhance our strategic position and accelerate long-term sales growth.

•Driving operational excellence and executing sustainable efficiency gains within our selling, general and administrative structures and within our global operations including insourcing of critical products and manufacturing activities while reducing our environmental footprint.

•Building on our culture of diversity, equity and inclusion to increase employee engagement and enhance recruitment and retention practices in order to drive differentiated performance and execute our strategy.

Macroeconomic Conditions and Trends

The Company continues to be impacted by inflationary pressures to raw material and labor costs, supply chain disruptions, and other global macroeconomic challenges. While we experienced material increases to raw material and labor costs and supply chain disruptions in previous years, fiscal 2024 showed signs of easing with a moderation of raw material and labor cost inflation and improved supply chain stability, which we anticipate will continue into fiscal 2025. The Company has taken and will continue to take actions to mitigate inflationary pressures through targeted pricing actions and a commitment to driving long-term efficiency improvements.

Table of Contents

We believe our financial strength positions us well to continue investing in acquisitions and organic growth opportunities, such as expanded sales channels, marketing programs, and research and development (“R&D”). We remain focused on driving sustainable efficiency gains and automation across our operations and selling, general and administrative (“SG&A”) functions, while also returning capital to our shareholders through dividends and share repurchases. At October 31, 2024, we had cash of $145.7 million, as well as a credit agreement with $181.5 million available for future borrowing, which can be increased up to $1,036.5 million at the Company's option and subject to certain conditions, for total available liquidity of $1,182.2 million.

We believe that our financial resources and liquidity levels, including the undrawn portion of our credit agreement and our ability to increase that credit line as necessary, are sufficient to support the execution of our growth strategy and to manage the impact of economic or geopolitical events that could potentially reduce sales, net income, or cash provided by operating activities. Refer to Risk Factors, included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended July 31, 2024, for further discussion of the possible impact of global economic or geopolitical events on our business.

Results of Operations

The comparability of the operating results for the three months ended October 31, 2024 compared to the three months ended October 31, 2023 has been impacted by acquisitions of Gravotech on August 1, 2024 and AB&R on October 1, 2024. The operating results of Gravotech have been included in both reportable segments since the date of acquisition, and the results of AB&R have been included in the Americas & Asia reportable segment since the date of acquisition. The comparability of the operating results of the Americas & Asia segment has also been impacted by the divestiture of a non-core business in October 2023.

A comparison of results of operating income for the three months ended October 31, 2024 and 2023 is as follows:


	Three months ended October 31,
(Dollars in thousands)	2024		% Sales		2023		% Sales
Net sales	$	377,065			$	331,983
Gross margin	189,689		50.3	%	171,719		51.7	%
Operating expenses:
Research and development	18,921		5.0	%	15,702		4.7	%
Selling, general and administrative	111,846		29.7	%	96,287		29.0	%
Total operating expenses	130,767		34.7	%	111,989		33.7	%
Operating income	$	58,922	15.6	%	$	59,730	18.0	%

References in this Form 10-Q to “organic sales” refer to sales calculated in accordance with GAAP, excluding the impact of foreign currency translation, sales recorded from acquired companies prior to the first anniversary date of their acquisition, and sales recorded from divested companies up to the first anniversary of their divestiture. The Company's organic sales disclosures exclude the effects of foreign currency translation as foreign currency translation is subject to volatility that can obscure underlying business trends. Management believes that the non-GAAP financial measure of organic sales is meaningful to investors as it provides them with useful information to aid in identifying underlying sales trends in our businesses and facilitating comparisons of our sales performance with prior periods.

Net sales for the three months ended October 31, 2024 increased 13.6% to $377.1 million compared to $332.0 million in the same period in the prior year. The increase consisted of organic sales growth of 3.6%, sales growth from acquisitions of 9.9% and an increase from foreign currency translation of 1.2%, partially offset by a decrease of 1.1% due to divestitures. Organic sales grew 5.1% in the Americas & Asia segment and 0.7% in the Europe & Australia segment during the three months ended October 31, 2024 compared to the same period in the prior year.

Gross margin increased 10.5% to $189.7 million in the three months ended October 31, 2024 compared to $171.7 million in the same period in the prior year. As a percentage of net sales, gross margin decreased to 50.3% in the three months ended October 31, 2024 compared to 51.7% in the same period in the prior year. The decrease in gross margin as a percentage of net sales was primarily due to a nonrecurring increase in cost of goods sold of $4.1 million related to the fair value adjustment to inventory from acquisitions and lower margin product sales from acquired businesses, which were partially offset by organic sales growth in higher gross margin product lines.

R&D expenses increased 20.5% to $18.9 million in the three months ended October 31, 2024 compared to $15.7 million in the same period in the prior year. As a percentage of net sales, R&D expenses increased to 5.0% in the three months ended October 31, 2024 compared to 4.7% in the same period in the prior year. The increase in R&D spending was primarily due to the acquisition of Gravotech, and, to a lesser extent, an increase in R&D headcount within the Company's organic business. The Company remains committed to investing in new product development to increase sales within our businesses. Investments in

Table of Contents

new printing systems, materials and the build out of a comprehensive industrial track and trace solution remain the primary focus of R&D expenditures in fiscal 2025.

SG&A expenses include selling and administrative costs directly attributed to the Americas & Asia and Europe & Australia segments, as well as certain other corporate administrative expenses including finance, information technology, human resources and other administrative expenses. SG&A expenses increased 16.2% to $111.8 million in the three months ended October 31, 2024 compared to $96.3 million in the same period in the prior year. As a percentage of net sales, SG&A increased to 29.7% in the three months ended October 31, 2024, compared to 29.0% in the same period in the prior year. The increase in SG&A as a percentage of net sales is primarily due to incremental amortization expense from acquisitions of $2.4 million, as well as increased headcount and other selling-related costs from the businesses acquired, which were partially offset by a decrease in advertising expenses in the Company's organic businesses compared to the same period in the prior year.

Operating income decreased 1.4% to $58.9 million in the three months ended October 31, 2024, compared to $59.7 million in the same period in the prior year. The decrease in operating income was due to incremental amortization expense from acquisitions of $2.4 million and non-recurring acquisition-related and other costs of $5.1 million incurred during the three-month period.

OPERATING INCOME TO NET INCOME


	Three months ended October 31,
(Dollars in thousands)	2024		% Sales		2023		% Sales
Operating income	$	58,922	15.6	%	$	59,730	18.0	%
Other income (expense):
Investment and other income	1,234		0.3	%	438		0.1	%
Interest expense	(1,356)		(0.4)	%	(766)		(0.2)	%
Income before income taxes	58,800		15.6	%	59,402		17.9	%
Income tax expense	12,017		3.2	%	12,161		3.7	%
Net income	$	46,783	12.4	%	$	47,241	14.2	%

Investment and other income was $1.2 million in the three months ended October 31, 2024 compared to $0.4 million in the same period in the prior year. The change was primarily due to an increase in the market value of securities held in deferred compensation plans, partially offset by a decrease in interest income resulting from a decrease in interest rates as well as a reduced cash balance.

Interest expense increased to $1.4 million in the three months ended October 31, 2024 compared to $0.8 million in the same period in the prior year. The increase in interest expense was primarily due to an increase in outstanding borrowings on the Company's credit agreement to fund the acquisitions completed during the three months ended October 31, 2024.

The Company’s income tax rate was 20.4% and 20.5% for the three months ended October 31, 2024 and 2023, respectively. The Company expects its ongoing annual income tax rate to be approximately 20% based on its current global business mix and based on tax laws and statutory rates currently in effect.

Business Segment Operating Results

The Company evaluates short-term segment performance based on segment profit and customer sales. Interest expense, investment and other income, income tax expense, and certain corporate administrative expenses are excluded when evaluating segment performance.

Table of Contents

The following is a summary of segment information for the three months ended October 31, 2024 and 2023:


	Three months ended October 31,
	2024			2023
SALES GROWTH INFORMATION
Americas & Asia
Organic	5.1		%	3.3		%
Currency	(0.2)		%	—		%
Acquisition	7.4		%	—		%
Divestiture	(1.6)		%	(1.9)		%
Total	10.7		%	1.4		%
Europe & Australia
Organic	0.7		%	1.4		%
Currency	3.6		%	4.6		%
Acquisition	15.0		%	—		%
Total	19.3		%	6.0		%
Total Company
Organic	3.6		%	2.7		%
Currency	1.2		%	1.5		%
Acquisition	9.9		%	—		%
Divestiture	(1.1)		%	(1.3)		%
Total	13.6		%	2.9		%
SEGMENT PROFIT
Americas & Asia	$	54,900		$	49,897
Europe & Australia	13,114			16,744
Total	$	68,014		$	66,641
SEGMENT PROFIT AS A PERCENT OF NET SALES
Americas & Asia	22.4		%	22.5		%
Europe & Australia	10.0		%	15.2		%
Total	18.0		%	20.1		%

Americas & Asia

Americas & Asia net sales increased 10.7% to $245.4 million in the three months ended October 31, 2024 compared to $221.6 million in the same period in the prior year, which consisted of organic sales growth of 5.1% and sales growth from acquisitions of 7.4%, which were partially offset by a decrease from foreign currency translation of 0.2% and a decrease of 1.6% due to the divestiture of a non-core business in October 2023.

Organic sales in the Americas increased in the mid-single digits in the three months ended October 31, 2024. Organic sales grew in all major products lines with the strongest growth in the product identification, wire identification, and safety and facility identification product lines.

Organic sales in Asia increased in the mid-single digits in the three months ended October 31, 2024. The organic sales increase was primarily driven by organic sales growth in Japan and India, which was partially offset by an organic sales decline in China.

Segment profit increased 10.0% to $54.9 million in the three months ended October 31, 2024 compared to $49.9 million in the same period in the prior year. As a percentage of net sales, segment profit was essentially flat at 22.4% compared to 22.5% in the same period in the prior year. The increase in segment profit was primarily due to increased sales volumes in the Americas, which was partially offset by certain acquisition-related costs and purchase accounting adjustments.

Europe & Australia

Europe & Australia net sales increased 19.3% to $131.6 million in the three months ended October 31, 2024 compared to $110.4 million in the same period in the prior year, which consisted of sales growth from acquisitions of 15.0%, organic sales growth of 0.7% and an increase from foreign currency translation of 3.6%.

Table of Contents

Organic sales in Europe increased in the low-single digits in the three months ended October 31, 2024. Organic sales growth during the three-month period was primarily driven by growth in the safety and facility identification and people identification product lines, which was partially offset by an organic sales decline in the product identification product line.

Organic sales in Australia declined in the low-single digits in the three months ended October 31, 2024. The organic sales decline was primarily driven by a decrease in volume in the wire identification product line.

Segment profit decreased to $13.1 million in the three months ended October 31, 2024 compared to $16.7 million in the same period of the prior year. As a percentage of net sales, segment profit decreased to 10.0% from 15.2% in the same period of the prior year. The decrease in segment profit was primarily due to certain acquisition-related costs and organizational transition costs incurred during the three-month period.

Liquidity and Capital Resources

The Company's cash balances are generated and held in numerous locations throughout the world. At October 31, 2024, approximately 95% of the Company's cash and cash equivalents were held outside the United States. The Company's organic and inorganic growth has historically been funded by a combination of cash provided by operating activities and debt financing. The Company believes that its cash flow from operating activities and its borrowing capacity are sufficient to fund its anticipated requirements for working capital, capital expenditures, research and development, common stock repurchases, and dividend payments for the next 12 months. Although the Company believes these sources of cash are currently sufficient to fund domestic operations, annual cash needs could require repatriation of cash to the U.S. from foreign jurisdictions, which may result in additional tax payments.

Cash Flows

Cash and cash equivalents were $145.7 million at October 31, 2024, a decrease of $104.5 million from July 31, 2024. The significant changes were as follows:


	Three months ended October 31,
(Dollars in thousands)	2024		2023
Net cash flow provided by (used in):
Operating activities	$	23,406	$	62,273
Investing activities	(147,901)		(11,279)
Financing activities	18,263		(21,494)
Effect of exchange rate changes on cash	1,775		(5,680)
Net (decrease) increase in cash and cash equivalents	$	(104,457)	$	23,820

Net cash provided by operating activities was $23.4 million in the three months ended October 31, 2024, compared to $62.3 million in the same period of the prior year. The decrease in cash provided by operating activities was primarily due to increased vendor payments related to the acquired businesses, the timing of payroll and higher annual incentive compensation payments, and other working capital changes.

Net cash used in investing activities was $147.9 million in the three months ended October 31, 2024, which primarily consisted of the acquisition of businesses of $140.6 million and capital expenditures of $7.3 million. Net cash used in investing activities was $11.3 million in the three months ended October 31, 2023, which consisted of capital expenditures.

Net cash provided by financing activities was $18.3 million in the three months ended October 31, 2024 compared to $21.5 million net cash used in financing activities in the same period of the prior year. The increase in cash provided by financing activities was primarily due to increased net borrowings to fund the acquisition of AB&R completed on October 1, 2024, and, to a lesser extent, a decline in share repurchases compared to the same period in the prior year.

Material Cash Requirements

Our material cash requirements for known contractual obligations include capital expenditures, borrowings on our credit agreement and lease obligations. We believe that net cash provided by operating activities will continue to be adequate to meet our liquidity and capital needs for these items over the next 12 months and in the long-term beyond the next 12 months. We also have cash requirements for purchase orders and contracts for the purchase of inventory and other goods and services, which are based on current and anticipated customer needs and are fulfilled by our suppliers within short time horizons. We do not have significant agreements for the purchase of inventory or other goods or services specifying minimum order quantities. In addition, we may have liabilities for uncertain tax positions, but we do not believe that the cash requirements to meet any of these liabilities will be material.

Table of Contents

Credit Agreement

On August 1, 2019, the Company and certain of its subsidiaries entered into an unsecured $200 million multi-currency credit agreement with a group of five banks.

On December 21, 2021, the Company and certain of its subsidiaries entered into an amendment to the credit agreement dated August 1, 2019 to adjust to alternative benchmarks due to the elimination of the London Inter-bank Offered Rate (“LIBOR”).

On November 14, 2022, the Company and certain of its subsidiaries entered into a second amendment to the credit agreement to, among other items, (a) increase the lending commitments by $100 million for total lending commitments of $300 million, (b) extend the final maturity date to November 14, 2027, (c) increase the interest rate on certain borrowings by 0.125%, and (d) increase the available amount under the credit agreement, at the Company's option and subject to certain conditions, from $300 million up to (i) an amount equal to the incremental borrowing necessary to bring the Company's consolidated net debt-to-EBITDA ratio as defined in the credit agreement to 2.5 to 1.0 plus (ii) $200 million.

On October 10, 2024, the Company and certain of its subsidiaries entered into a Third Amendment to Credit Agreement (“Amendment No. 3”) with a group of six banks, which amended the original credit agreement dated August 1, 2019. Amendment No. 3 amended the credit agreement to, among other things, change the applicable benchmark under the credit agreement for borrowings denominated in Canadian Dollars from the Canadian Dollar Offered Rate (“CDOR”) to the adjusted Term Canadian Overnight Repo Rate Average Rate (“CORRA”). Borrowings under Amendment No. 3 are unsecured and are guaranteed by certain of the Company's domestic subsidiaries.

As of October 31, 2024, the outstanding balance on the Company's credit agreement was $116.6 million. The maximum amount outstanding on the credit agreement during the three months ended October 31, 2024 was $144.8 million. As of October 31, 2024, the U.S. dollar-denominated borrowings of $52.0 million bear interest at 5.8%; the Euro-denominated borrowings of €50.0 million bear interest at 4.1%; and the British Pound-denominated borrowings of £8.0 million bear interest at 5.8%. The Company had letters of credit outstanding under the credit agreement of $1.8 million as of October 31, 2024 and there was $181.5 million available for future borrowing, which can be increased to $1,036.5 million at the Company's option, subject to certain conditions. The credit agreement has a final maturity date of November 14, 2027. As such, borrowings were classified as long-term on the condensed consolidated balance sheets.

Covenant Compliance

The Company's credit agreement requires it to maintain certain financial covenants, including a ratio of debt to the trailing twelve months EBITDA, as defined in the debt agreements, of not more than a 3.5 to 1.0 ratio (leverage ratio) and the trailing twelve months EBITDA to interest expense of not less than a 3.0 to 1.0 ratio (interest expense coverage). As of October 31, 2024, the Company was in compliance with these financial covenants, with a ratio of debt to EBITDA, as defined by the agreements, equal to 0.4 to 1.0 and the interest expense coverage ratio equal to 83.8 to 1.0.

Forward-Looking Statements

In this quarterly report on Form 10-Q, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from:

•Increased cost of raw materials and labor as well as material shortages and supply chain disruptions

•Decreased demand for the Company's products

•Ability to compete effectively or to successfully execute the Company's strategy

•Ability to develop technologically advanced products that meet customer demands

•Ability to identify, integrate, and grow acquired companies, and to manage contingent liabilities from divested businesses

•Difficulties in protecting websites, networks, and systems against security breaches and difficulties in preventing phishing attacks, social engineering or malicious break-ins

Table of Contents

•Risks associated with the loss of key employees

•Global climate change and environmental regulations

•Litigation, including product liability claims

•Foreign currency fluctuations

•Changes in tax legislation and tax rates

•Potential write-offs of goodwill and other intangible assets

•Differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures

•Numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady's Form 10-K for the year ended July 31, 2024.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Refer to the Company’s annual report on Form 10-K for the year ended July 31, 2024. There has been no material change in this information since the 2024 Form 10-K.

ITEM 4. CONTROLS AND PROCEDURES

Brady Corporation maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in the reports filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports the Company files under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company carried out an evaluation, under the supervision and with the participation of its management, including its President and Chief Executive Officer (the “Chief Executive Officer”) and its Chief Financial Officer, Chief Accounting Officer and Treasurer (the “Chief Financial Officer”), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report.

There were no changes in the Company's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the Company's most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The information set forth in Note N, "Contingencies" included in this Quarterly Report on Form 10-Q is incorporated herein by reference.

ITEM 1A. RISK FACTORS

The Company’s business, results of operations, financial condition, and cash flows are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” of Company’s Annual Report on Form 10-K for the year ended July 31, 2024. There have been no material changes from the risk factors set forth in the 2024 Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The Company maintains a share repurchase program for the Company's Class A Nonvoting Common Stock. The program may be implemented by purchasing shares in the open market or in privately negotiated transactions, with repurchased shares available for use in connection with the Company's stock-based plans and for other corporate purposes.

On September 4, 2024, the Company's Board of Directors authorized an increase in the Company's share repurchase program, authorizing the repurchase of an additional $100.0 million of the Company's Class A Nonvoting Common Stock, which expanded upon the Company's prior authorization for a total authorized amount of $137.8 million. The share repurchase program may be implemented from time to time on the open market or in privately negotiated transactions and has no expiration date. As of October 31, 2024, there were $137.8 million worth of shares authorized to purchase remaining pursuant to the existing share repurchase program.

The following table provides information with respect to the purchases by the Company of Class A Nonvoting Common Stock during the three months ended October 31, 2024:


Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (Dollars in Thousands)
August 1, 2024 - August 31, 2024	—	$	—	—	$	137,788
September 1, 2024 - September 30, 2024	—	—		—	137,788
October 1, 2024 - October 31, 2024	—	—		—	137,788
Total	—	$	—	—	$	137,788

ITEM 5. OTHER INFORMATION

During the three months ended October 31, 2024, no director or Section 16 officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is identified in Item 408(a) of Regulation S-K.

Table of Contents

ITEM 6. EXHIBITS


Exhibit No.						Exhibit Description

10.1						Third Amendment to Credit Agreement, dated as of October 10, 2024, by and among Brady Corporation and certain of its subsidiaries, the lenders listed therein and BMO Bank N.A., as administrative agent (incorporated by reference to Registrant's Current Report on Form 8-K filed October 11, 2024).

31.1						Rule 13a-14(a)/15d-14(a) Certification of Russell R. Shaller

31.2						Rule 13a-14(a)/15d-14(a) Certification of Ann E. Thornton

32.1						Section 1350 Certification of Russell R. Shaller

32.2						Section 1350 Certification of Ann E. Thornton

101.INS						Inline XBRL Instance Document (The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.)

101.SCH						Inline XBRL Extension Taxonomy Schema Document

101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB						Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE						Inline XBRL Taxonomy Extension Presentation Label Linkbase Document

104						Cover Page Interactive Data File (Formatted as Inline XBRL contained in Exhibit 101)

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

BRADY CORPORATION

Date: November 18, 2024

/s/ RUSSELL R. SHALLER

Russell R. Shaller

President and Chief Executive Officer

(Principal Executive Officer)

Date: November 18, 2024

/s/ ANN E. THORNTON

Ann E. Thornton

Chief Financial Officer, Chief Accounting Officer and Treasurer

(Principal Financial Officer and Principal Accounting Officer)

EXHIBIT 31.1

RULE 13a-14(a)/15d-14(a) CERTIFICATION

I, Russell R. Shaller, certify that:

(1) I have reviewed this quarterly report on Form 10-Q of Brady Corporation;

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material act necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4) I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision to provided reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5) I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date: November 18, 2024

/s/ RUSSELL R. SHALLER
President & Chief Executive Officer
(Principal Executive Officer)

EXHIBIT 31.2

RULE 13a-14(a)/15d-14(a) CERTIFICATION

I, Ann E. Thornton, certify that:

(1) I have reviewed this quarterly report on Form 10-Q of Brady Corporation;

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date: November 18, 2024

/s/ ANN E. THORNTON
Chief Financial Officer, Chief Accounting Officer and Treasurer
(Principal Financial Officer and Principal Accounting Officer)

EXHIBIT 32.1

SECTION 1350 CERTIFICATION

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Brady Corporation (the “Company”) certifies to his knowledge that:

(1) The Quarterly Report on Form 10-Q of the Company for the quarterly period ended October 31, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.



Date: November 18, 2024

/s/ RUSSELL R. SHALLER
President & Chief Executive Officer
(Principal Executive Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. This certification accompanies this report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

EXHIBIT 32.2

SECTION 1350 CERTIFICATION

(2) The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.



Date: November 18, 2024

/s/ ANN E. THORNTON
Chief Financial Officer, Chief Accounting Officer and Treasurer
(Principal Financial Officer and Principal Accounting Officer)

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Oct. 31, 2024	Nov. 14, 2024
Entity Information [Line Items]
Document Type	10-Q
Entity Registrant Name	BRADY CORP
Document Quarterly Report	true
Document Transition Report	false
Security Exchange Name	NYSE
Title of 12(b) Security	Class A Nonvoting Common Stock, par value $0.01 per share
Trading Symbol	BRC
Entity File Number	1-14959
Entity Interactive Data Current	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Tax Identification Number	39-0178960
Entity Address, Address Line One	6555 West Good Hope Road
Entity Address, State or Province	WI
Entity Address, Postal Zip Code	53223
Entity Incorporation, State or Country Code	WI
City Area Code	Milwaukee
City Area Code	414
Local Phone Number	358-6600
Document Period End Date	Oct. 31, 2024
Amendment Flag	false
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q1
Entity Central Index Key	0000746598
Current Fiscal Year End Date	--07-31
Class A Nonvoting Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		44,223,720
Class B Voting Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		3,538,628

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Current assets:
Cash and cash equivalents	$ 145,661	$ 250,118
Accounts receivable, net of allowance for credit losses of $10,295 and $6,749, respectively	218,258	185,486
Inventories	178,688	152,729
Prepaid expenses and other current assets	13,462	11,382
Total current assets	556,069	599,715
Assets, Noncurrent
Property, plant and equipment—net	201,374	195,758
Goodwill	671,705	589,611
Other intangible assets	116,369	51,839
Deferred income taxes	16,841	15,596
Operating lease assets	42,157	38,504
Other assets	23,361	24,546
Total	1,627,876	1,515,569
Current liabilities:
Accounts payable	98,179	84,691
Accrued compensation and benefits	65,004	77,954
Taxes, other than income taxes	22,901	14,061
Accrued income taxes	11,994	7,424
Current operating lease liabilities	13,120	13,382
Other current liabilities	90,272	67,170
Total current liabilities	301,470	264,682
Other Long-Term Debt, Noncurrent	116,645	90,935
Long-term operating lease liabilities	29,201	25,342
Other liabilities	71,628	67,952
Total liabilities	518,944	448,911
Stockholders’ equity:
Additional paid-in capital	354,592	353,654
Retained earnings	1,209,406	1,174,025
Treasury stock—7,037,823 and 7,219,025 shares, respectively, of Class A nonvoting common stock, at cost	(344,012)	(351,947)
Accumulated other comprehensive loss	(111,602)	(109,622)
Total stockholders’ equity	1,108,932	1,066,658
Total	1,627,876	1,515,569
Class A Nonvoting Common Stock
Stockholders’ equity:
Common Stock, Value, Issued	513	513
Class B Voting Common Stock
Stockholders’ equity:
Common Stock, Value, Issued	$ 35	$ 35

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Accounts Receivable, Allowance for Credit Loss, Current	$ 10,295	$ 6,749
Class A Nonvoting Common Stock
Common stock, shares issued	51,261,487	51,261,487
Common stock, shares outstanding	44,223,664	44,042,462
Treasury Stock, Common, Shares	7,037,823	7,219,025
Class B Voting Common Stock
Common stock, shares issued	3,538,628	3,538,628
Common stock, shares outstanding	3,538,628	3,538,628

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Net sales	$ 377,065	$ 331,983
Cost of goods sold	187,376	160,264
Gross margin	189,689	171,719
Operating expenses:
Research and development	18,921	15,702
Selling, general and administrative	111,846	96,287
Total operating expenses	130,767	111,989
Operating income	58,922	59,730
Other income (expense):
Investment and other income	1,234	438
Interest expense	(1,356)	(766)
Income before income taxes	58,800	59,402
Income tax expense	12,017	12,161
Net income	$ 46,783	$ 47,241
Weighted average common shares outstanding:
Basic	47,732	48,505
Diluted	48,217	48,811
Class A Nonvoting Common Stock
Earnings Per Share
Basic	$ 0.98	$ 0.97
Diluted	0.97	0.97
Class B Voting Common Stock
Earnings Per Share
Basic	0.96	0.96
Diluted	$ 0.95	$ 0.95

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 46,783	$ 47,241
Other comprehensive loss:
Foreign currency translation adjustments	(79)	(20,364)
Cash flow hedges:
Net loss recognized in other comprehensive loss	(1,338)	(294)
Reclassification adjustment for gains included in net income	464	1,285
Other Comprehensive (Loss) Income, Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax	(1,802)	(1,579)
Pension and other post-retirement benefits:
Pension and other post-retirement benefits actuarial gain amortization	(151)	(151)
Other comprehensive loss, before tax	(2,032)	(22,094)
Income tax benefit (expense) related to items of other comprehensive loss	52	(128)
Other comprehensive loss, net of tax	(1,980)	(22,222)
Comprehensive income	$ 44,803	$ 25,019

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Class A Nonvoting Common Stock	Class B Voting Common Stock	Common Stock	Additional Paid-in Capital	Retained Earnings	Retained Earnings Class A Nonvoting Common Stock	Retained Earnings Class B Voting Common Stock	AOCI Attributable to Parent	Treasury Stock, Common
Beginning Balances at Jul. 31, 2023	$ 990,919			$ 548	$ 351,771	$ 1,021,870			$ (93,061)	$ (290,209)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	47,241					47,241
Other Comprehensive Income (Loss), Net of Tax	22,222								22,222
Issuance of shares of Class A Common Stock under stock plan	(265)				3,662					3,927
Tax benefit and withholdings from deferred compensation distributions	149				149
Repurchase of shares of Class A Common Stock, including excise taxes										(14,185)
Stock-based compensation expense	4,163				4,163
Dividends, Common Stock, Cash		$ 10,565	$ 773				$ 10,565	$ 773
Ending Balances at Oct. 31, 2023	994,992			548	352,421	1,057,773			(115,283)	(300,467)
Beginning Balances at Jul. 31, 2024	1,066,658			548	353,654	1,174,025			(109,622)	(351,947)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	46,783
Other Comprehensive Income (Loss), Net of Tax	1,980								1,980
Issuance of shares of Class A Common Stock under stock plan	(2,870)				5,065					7,935
Tax benefit and withholdings from deferred compensation distributions	190				190
Stock-based compensation expense	5,813				5,813
Dividends, Common Stock, Cash		$ 10,612	$ 790				$ 10,612	$ 790
Ending Balances at Oct. 31, 2024	$ 1,108,932			$ 548	$ 354,592	$ 1,209,406			$ (111,602)	$ (344,012)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Class A Nonvoting Common Stock
Common Stock, Dividends, Per Share, Declared	$ 0.2400	$ 0.2350
Class B Voting Common Stock
Common Stock, Dividends, Per Share, Declared	$ 0.2234	$ 0.2184

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Operating activities:
Net income	$ 46,783	$ 47,241
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	10,164	7,466
Stock-based compensation expense	5,813	4,163
Deferred income taxes	(903)	(2,225)
Other	(880)	1,137
Changes in operating assets and liabilities:
Accounts receivable	(4,385)	(2,205)
Inventories	(2,107)	6,152
Prepaid expenses and other assets	(1,136)	(1,488)
Accounts payable and accrued liabilities	(33,960)	(3,725)
Income taxes	4,017	5,757
Net cash provided by operating activities	23,406	62,273
Investing activities:
Purchases of property, plant and equipment	(7,286)	(11,279)
Payments to Acquire Businesses, Net of Cash Acquired	(140,625)	0
Payments for (Proceeds from) Other Investing Activities	10	0
Net cash used in investing activities	(147,901)	(11,279)
Financing activities:
Payment of dividends	(11,402)	(11,338)
Proceeds from exercise of stock options	5,855	2,598
Payments for employee taxes withheld from stock-based awards	(2,090)	(2,333)
Purchase of treasury stock	0	(14,121)
Proceeds from borrowing on credit agreement	135,149	38,551
Repayment of borrowing on credit agreement	(109,439)	(36,000)
Other	190	1,149
Net cash provided by (used in) financing activities	18,263	(21,494)
Effect of exchange rate changes on cash and cash equivalents	1,775	(5,680)
Net (decrease) increase in cash and cash equivalents	(104,457)	23,820
Cash and cash equivalents, beginning of period	250,118	151,532
Cash and cash equivalents, end of period	$ 145,661	$ 175,352

Basis of Presentation (Notes)	3 Months Ended
Basis of Presentation (Notes)	Oct. 31, 2024
Text Block [Abstract]
Basis of Presentation	Basis of Presentation The condensed consolidated financial statements included herein have been prepared by Brady Corporation and subsidiaries (the “Company,” “Brady,” “we,” or “our”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of the Company, the foregoing statements contain all adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial position of the Company as of October 31, 2024 and July 31, 2024, its results of operations, cash flows and comprehensive income for the three months ended October 31, 2024 and 2023. The condensed consolidated balance sheet as of July 31, 2024 has been derived from the audited consolidated financial statements as of that date. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts therein. Due to the inherent uncertainty involved in making estimates, actual results in future periods may differ from the estimates. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to rules and regulations of the Securities and Exchange Commission. Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statement presentation. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended July 31, 2024.

New Accounting Pronouncements (Notes)	3 Months Ended
New Accounting Pronouncements (Notes)	Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
New Accounting Pronouncements	New Accounting Pronouncements Standards not yet adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The guidance requires expanded interim and annual disclosures of segment information including the disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within segment profit and loss. The guidance is effective for the Company's fiscal 2025 Form 10-K and interim periods thereafter. The Company is currently assessing its segment information disclosures in connection with the adoption of ASU 2023-07. In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” The guidance requires expanded annual disclosures including the standardization and disaggregation of income tax rate reconciliation categories and the amount of income taxes paid by jurisdiction. The guidance is effective for the Company’s fiscal 2026 Form 10-K. The Company is currently assessing its income tax disclosures in connection with the adoption of ASU 2023-09. In November 2024, the FASB issued ASU 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” The guidance requires expanded interim and annual disclosures of expense information including the amounts of inventory purchases, employee compensation, depreciation, amortization, and depletion within commonly presented expense captions during the period. The guidance is effective for the Company's fiscal 2028 Form 10-K and interim periods thereafter. The Company is currently evaluating the ASU to determine its impact on the Company's disclosures.

Additional Balance Sheet Disclosures (Notes)

3 Months Ended

Oct. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Additional Balance Sheet Information

Inventories

Inventories consisted of the following as of October 31, 2024 and July 31, 2024:


	October 31, 2024		July 31, 2024
Finished products	$	103,375	$	89,430
Work-in-process	27,029		24,601
Raw materials and supplies	48,284		38,698
Total inventories	$	178,688	$	152,729

Property, plant and equipment

Property, plant and equipment is presented net of accumulated depreciation in the amount of $308,128 and $304,199 as of October 31, 2024 and July 31, 2024, respectively.

Other Intangible Assets (Notes)

3 Months Ended

Oct. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Other Intangible Assets

Other intangible assets as of October 31, 2024 and July 31, 2024 consisted of the following:


	October 31, 2024							July 31, 2024
	Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value
Amortized other intangible assets:
Tradenames	2	$	868	$	(108)	$	760	3	$	600	$	(600)	$	—
Customer relationships	8	122,289		(26,899)		95,390		9	64,430		(23,279)		41,151
Technology	5	19,857		(7,215)		12,642		5	9,300		(6,182)		3,118
Unamortized other intangible assets:
Tradenames	N/A	7,577		—		7,577		N/A	7,570		—		7,570
Total		$	150,591	$	(34,222)	$	116,369		$	81,900	$	(30,061)	$	51,839

Amortization expense on intangible assets was $4,713 and $2,355 for the three months ended October 31, 2024 and 2023, respectively.

Leases (Notes)

3 Months Ended

Oct. 31, 2024

Leases [Abstract]

Leases

Supplemental cash flow information related to the Company's operating leases for the three months ended October 31, 2024 and 2023 was as follows:


	Three months ended October 31,
	2024		2023
Operating cash flows from operating leases	$	4,619	$	4,431
Operating lease assets obtained in exchange for new operating lease liabilities (1)	7,630		1,656

(1) Includes new leases, acquired leases and remeasurements or modifications of existing leases.

Accumulated Other Comprehensive Loss (Notes)

3 Months Ended

Oct. 31, 2024

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Accumulated Other Comprehensive Loss

The following table illustrates the changes in the balances of each component of accumulated other comprehensive loss, net of tax, for the three months ended October 31, 2024:


	Unrealized loss on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2024	$	(149)	$	462	$	(109,935)	$	(109,622)
Other comprehensive loss before reclassification	(1,402)		—		(79)		(1,481)
Amounts reclassified from accumulated other comprehensive loss	(348)		(151)		—		(499)
Ending balance, October 31, 2024	$	(1,899)	$	311	$	(110,014)	$	(111,602)

The increase in accumulated other comprehensive loss as of October 31, 2024 compared to July 31, 2024 was primarily due to the unrealized losses on cash flow hedges during the three-month period.

The changes in accumulated other comprehensive loss by component, net of tax, for the three months ended October 31, 2023 were as follows:


	Unrealized gain (loss) on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2023	$	1,641	$	756	$	(95,458)	$	(93,061)
Other comprehensive loss before reclassification	(744)		—		(20,364)		(21,108)
Amounts reclassified from accumulated other comprehensive loss	(963)		(151)		—		(1,114)
Ending balance, October 31, 2023	$	(66)	$	605	$	(115,822)	$	(115,283)

The following table illustrates the income tax benefit (expense) on the components of other comprehensive loss for the three months ended October 31, 2024 and 2023:


	Three months ended October 31,
	2024		2023
Income tax benefit (expense) related to items of other comprehensive loss:
Cash flow hedges	$	52	$	(128)

Revenue Recognition (Notes)	3 Months Ended
Revenue Recognition (Notes)	Oct. 31, 2024
Revenue Recognition [Abstract]
Revenue Recognition	Revenue Recognition The Company recognizes revenue when control of the product or service transfers to the customer at an amount that represents the consideration expected to be received in exchange for those products and services. The Company’s revenues are primarily from the sale of identification solutions and workplace safety products that are shipped and billed to customers. All revenue is from contracts with customers and is included in “Net sales” on the condensed consolidated statements of income. See Note H, “Segment Information,” for the Company’s disaggregated revenue disclosure. The Company offers extended warranty coverage that is included in the sales price of certain products, which it accounts for as service warranties. The Company accounts for the deferred revenue associated with extended service warranties as a contract liability. The balance of contract liabilities associated with service warranty performance obligations was $2,973 and $2,947 as of October 31, 2024 and July 31, 2024, respectively. The current portion and non-current portion of contract liabilities are included in “Other current liabilities” and “Other liabilities,” respectively, on the condensed consolidated balance sheets. The Company recognized revenue of $337 and $314 during the three months ended October 31, 2024 and 2023, respectively, that was included in the contract liability balance at the beginning of the respective period from the amortization of extended service warranties. Of the contract liability balance outstanding at October 31, 2024, the Company expects to recognize 32% by the end of fiscal 2025, an additional 31% by the end of fiscal 2026, and the remaining balance thereafter.

Segment Information (Notes)

3 Months Ended

Oct. 31, 2024

Segment Reporting [Abstract]

Segment Information

The Company is organized and managed within two regions: Americas & Asia and Europe & Australia, which are the reportable segments.

The following is a summary of net sales by segment and geographic region for the three months ended October 31, 2024 and 2023:


	Three months ended October 31,
	2024		2023
Net sales:
Americas & Asia
Americas	$	214,033	$	196,286
Asia	31,395		25,340
Total	$	245,428	$	221,626
Europe & Australia
Europe	116,153		96,333
Australia	15,484		14,024
Total	$	131,637	$	110,357

Total Company	$	377,065	$	331,983

The following is a summary of segment profit for the three months ended October 31, 2024 and 2023:


	Three months ended October 31,
	2024		2023
Segment profit:
Americas & Asia	$	54,900	$	49,897
Europe & Australia	13,114		16,744
Total Company	$	68,014	$	66,641

The following is a reconciliation of segment profit to income before income taxes for the three months ended October 31, 2024 and 2023:


	Three months ended October 31,
	2024		2023
Total profit from reportable segments	$	68,014	$	66,641
Unallocated amounts:
Administrative costs	(9,092)		(6,911)
Investment and other income	1,234		438
Interest expense	(1,356)		(766)
Income before income taxes	$	58,800	$	59,402

Stock-Based Compensation (Notes)

3 Months Ended

Oct. 31, 2024

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stock-Based Compensation

Incentive Stock Plans

Stock Options

The following is a summary of stock option activity for the three months ended October 31, 2024:


Time-Based Options	Options Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at July 31, 2024	1,222,046	$	44.46
Granted	—	—
Exercised	(128,803)	38.83
Forfeited	(1,720)	50.19
Outstanding at October 31, 2024	1,091,523	$	45.12	5.4	$	28,592
Exercisable at October 31, 2024	1,010,597	$	44.84	5.2	$	26,754

The following table summarizes additional stock option information:


	Three months ended October 31,
	2024		2023

Intrinsic value of options exercised during the period (in thousands)	$	4,622	$	3,410
Fair value of options vested during the period (in thousands)	1,249		1,729
Cash received from the exercise of stock options during the period (in thousands)	5,855		2,598
Tax benefit on options exercised during the period (in thousands)	1,112		841

RSUs

The following is a summary of RSU activity for the three months ended October 31, 2024:


	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested RSUs as of July 31, 2024	148,991	$	52.20
Granted	88,319	74.63
Vested	(56,393)	51.07
Forfeited	(763)	58.94
Non-vested RSUs as of October 31, 2024	180,154	$	63.53

PRSUs

The following is a summary of PRSU activity for the three months ended October 31, 2024:


	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested PRSUs as of July 31, 2024	103,221	$	53.46
Granted	61,981	71.24
Vested	(8,098)	64.44
Forfeited	(2,157)	55.23
Non-vested PRSUs as of October 31, 2024	154,947	$	59.95

Net Income per Common Share (Notes)

3 Months Ended

Oct. 31, 2024

Earnings Per Share [Abstract]

Net Income per Common Share

Reconciliations of the numerator and denominator of the basic and diluted per share computations for the Company’s Class A and Class B common stock are summarized as follows:


	Three months ended October 31,
	2024		2023
Numerator (in thousands):
Net income (Numerator for basic and diluted income per Class A Nonvoting Common Share)	$	46,783	$	47,241
Less:
Preferential dividends	(736)		(748)
Preferential dividends on dilutive stock options	(8)		(5)
Numerator for basic and diluted income per Class B Voting Common Share	$	46,039	$	46,488
Denominator (in thousands):
Denominator for basic income per share for both Class A and Class B	47,732		48,505
Plus: Effect of dilutive equity awards	485		306
Denominator for diluted income per share for both Class A and Class B	48,217		48,811
Net income per Class A Nonvoting Common Share:
Basic	$	0.98	$	0.97
Diluted	$	0.97	$	0.97
Net income per Class B Voting Common Share:
Basic	$	0.96	$	0.96
Diluted	$	0.95	$	0.95

Fair Value Measurements (Notes)

3 Months Ended

Oct. 31, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurements

Level 1 — Unadjusted quoted prices in active markets for identical instruments that are accessible as of the reporting date.

Level 2 — Other significant pricing inputs that are either directly or indirectly observable.

Level 3 — Significant unobservable pricing inputs, which result in the use of management's own assumptions.

The following table summarizes the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis at October 31, 2024 and July 31, 2024:


	October 31, 2024		July 31, 2024		Fair Value Hierarchy
Assets:
Deferred compensation plan assets	$	18,180	$	20,029	Level 1
Foreign exchange contracts	148		137		Level 2
Liabilities:
Foreign exchange contracts	1,614		730		Level 2

The following methods and assumptions were used to estimate the fair value of each class of financial instrument:

The fair values of cash and cash equivalents, accounts receivable, accounts payable, and other liabilities approximated carrying values due to their short-term nature.

Derivatives and Hedging Activities (Notes)

3 Months Ended

Oct. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives and Hedging Activities

The U.S. dollar equivalent notional amounts of outstanding forward exchange contracts were as follows:


	October 31, 2024		July 31, 2024
Designated as cash flow hedges	$	44,448	$	59,207
Non-designated hedges	4,171		4,459
Total foreign exchange contracts	$	48,619	$	63,666

Cash Flow Hedges

Net Investment Hedges

The following table summarizes the amount of pre-tax gains and losses related to derivatives designated as hedging instruments:


	Three months ended October 31,
	2024		2023
(Losses) gains recognized in OCI:
Forward exchange contracts (cash flow hedges)	$	(1,338)	$	(294)
Foreign currency denominated debt (net investment hedges)	(190)		1,508
Gains reclassified from OCI into cost of goods sold:
Forward exchange contracts (cash flow hedges)	464		1,285

Fair values of derivative instruments in the condensed consolidated balance sheets were as follows:


	October 31, 2024						July 31, 2024
	Prepaid expenses and other current assets		Other current liabilities		Long-term Obligations		Prepaid expenses and other current assets		Other current liabilities		Long-term Obligations
Derivatives designated as hedging instruments:
Foreign exchange contracts (cash flow hedges)	$	148	$	1,610	$	—	$	137	$	726	$	—
Foreign currency denominated debt (net investment hedges)	—		—		34,251		—		—		34,060
Derivatives not designated as hedging instruments:
Foreign exchange contracts (non-designated hedges)	—		4		—		—		4		—
Total derivative instruments	$	148	$	1,614	$	34,251	$	137	$	730	$	34,060

Income Taxes (Notes)	3 Months Ended
Income Taxes (Notes)	Oct. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesThe income tax rate for the three months ended October 31, 2024 and 2023 was 20.4% and 20.5%, respectively.

Commitment and Contingencies (Notes)	3 Months Ended
Commitment and Contingencies (Notes)	Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure	Contingencies In the normal course of business, the Company is subject to a variety of investigations, claims, suits, and other legal proceedings, including but not limited to, intellectual property, employment, unclaimed property, tort, and breach of contract matters. Any legal proceedings are subject to inherent uncertainties, and these matters and their potential effects may change in the future. The Company records a liability for contingencies when a loss is deemed to be probable and the loss can be reasonably estimated. The Company currently believes that the outcomes of such proceedings will not have a material adverse impact on its business, financial position, results of operations or cash flows.

Acquisition

3 Months Ended

Oct. 31, 2024

Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]

Business Combination Disclosure

Acquisitions

The following table summarizes the preliminary fair value of the assets acquired and liabilities assumed at the date of the acquisition:


Cash and cash equivalents	$	7,667
Accounts receivable, net	24,325
Inventories	21,751
Prepaid expenses and other current assets	563
Property, plant and equipment — net	2,538
Goodwill	71,790
Other intangible assets	65,798
Operating lease assets	6,981
Other assets	1,061
Accounts payable	(17,813)
Accrued compensation and benefits	(9,347)
Taxes, other than income taxes	(6,857)
Accrued income taxes	(1,855)
Other current liabilities	(18,157)
Operating lease liabilities	(6,980)
Other liabilities	(6,908)
Net assets acquired	$	134,557
Less: cash acquired	(7,667)

Fair value of total consideration	$	126,890


	Three months ended October 31,
	2024		2023
Net sales, pro forma	$	377,065	$	361,109
Net income, pro forma	46,783		43,535

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 31, 2023
Pay vs Performance Disclosure
Net income	$ 46,783	$ 47,241

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Oct. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Revenue Recognition and Deferred Revenue (Policies)	3 Months Ended
Revenue Recognition and Deferred Revenue (Policies)	Oct. 31, 2024
Revenue Recognition and Deferred Revenue [Abstract]
Revenue Recognition	Revenue Recognition The Company recognizes revenue when control of the product or service transfers to the customer at an amount that represents the consideration expected to be received in exchange for those products and services. The Company’s revenues are primarily from the sale of identification solutions and workplace safety products that are shipped and billed to customers. All revenue is from contracts with customers and is included in “Net sales” on the condensed consolidated statements of income. See Note H, “Segment Information,” for the Company’s disaggregated revenue disclosure. The Company offers extended warranty coverage that is included in the sales price of certain products, which it accounts for as service warranties. The Company accounts for the deferred revenue associated with extended service warranties as a contract liability. The balance of contract liabilities associated with service warranty performance obligations was $2,973 and $2,947 as of October 31, 2024 and July 31, 2024, respectively. The current portion and non-current portion of contract liabilities are included in “Other current liabilities” and “Other liabilities,” respectively, on the condensed consolidated balance sheets. The Company recognized revenue of $337 and $314 during the three months ended October 31, 2024 and 2023, respectively, that was included in the contract liability balance at the beginning of the respective period from the amortization of extended service warranties. Of the contract liability balance outstanding at October 31, 2024, the Company expects to recognize 32% by the end of fiscal 2025, an additional 31% by the end of fiscal 2026, and the remaining balance thereafter.

Additional Balance Sheet Disclosures (Tables)

3 Months Ended

Oct. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Inventory

Inventories consisted of the following as of October 31, 2024 and July 31, 2024:


	October 31, 2024		July 31, 2024
Finished products	$	103,375	$	89,430
Work-in-process	27,029		24,601
Raw materials and supplies	48,284		38,698
Total inventories	$	178,688	$	152,729

Goodwill and Other Intangible Assets (Tables)

3 Months Ended

Oct. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Other Intangible Assets

Other intangible assets as of October 31, 2024 and July 31, 2024 consisted of the following:


	October 31, 2024							July 31, 2024
	Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value
Amortized other intangible assets:
Tradenames	2	$	868	$	(108)	$	760	3	$	600	$	(600)	$	—
Customer relationships	8	122,289		(26,899)		95,390		9	64,430		(23,279)		41,151
Technology	5	19,857		(7,215)		12,642		5	9,300		(6,182)		3,118
Unamortized other intangible assets:
Tradenames	N/A	7,577		—		7,577		N/A	7,570		—		7,570
Total		$	150,591	$	(34,222)	$	116,369		$	81,900	$	(30,061)	$	51,839

Leases (Tables)

3 Months Ended

Oct. 31, 2024

Leases [Abstract]

Schedule of Cash Flow, Supplemental Lease Disclosures

Supplemental cash flow information related to the Company's operating leases for the three months ended October 31, 2024 and 2023 was as follows:


	Three months ended October 31,
	2024		2023
Operating cash flows from operating leases	$	4,619	$	4,431
Operating lease assets obtained in exchange for new operating lease liabilities (1)	7,630		1,656

Accumulated Other Comprehensive Loss (Tables)

3 Months Ended

Oct. 31, 2024

Oct. 31, 2023

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The following table illustrates the changes in the balances of each component of accumulated other comprehensive loss, net of tax, for the three months ended October 31, 2024:


	Unrealized loss on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2024	$	(149)	$	462	$	(109,935)	$	(109,622)
Other comprehensive loss before reclassification	(1,402)		—		(79)		(1,481)
Amounts reclassified from accumulated other comprehensive loss	(348)		(151)		—		(499)
Ending balance, October 31, 2024	$	(1,899)	$	311	$	(110,014)	$	(111,602)

The changes in accumulated other comprehensive loss by component, net of tax, for the three months ended October 31, 2023 were as follows:


	Unrealized gain (loss) on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2023	$	1,641	$	756	$	(95,458)	$	(93,061)
Other comprehensive loss before reclassification	(744)		—		(20,364)		(21,108)
Amounts reclassified from accumulated other comprehensive loss	(963)		(151)		—		(1,114)
Ending balance, October 31, 2023	$	(66)	$	605	$	(115,822)	$	(115,283)

Schedule of Income Tax Benefit on the Components of Other Comprehensive Loss

The following table illustrates the income tax benefit (expense) on the components of other comprehensive loss for the three months ended October 31, 2024 and 2023:


	Three months ended October 31,
	2024		2023
Income tax benefit (expense) related to items of other comprehensive loss:
Cash flow hedges	$	52	$	(128)

Segment Information (Tables)

3 Months Ended

Oct. 31, 2024

Segment Reporting [Abstract]

Revenue from External Customers by Geographic Areas [Table Text Block]

The following is a summary of net sales by segment and geographic region for the three months ended October 31, 2024 and 2023:


	Three months ended October 31,
	2024		2023
Net sales:
Americas & Asia
Americas	$	214,033	$	196,286
Asia	31,395		25,340
Total	$	245,428	$	221,626
Europe & Australia
Europe	116,153		96,333
Australia	15,484		14,024
Total	$	131,637	$	110,357

Total Company	$	377,065	$	331,983

Schedule of Segment Reporting Information by Segment

The following is a summary of segment profit for the three months ended October 31, 2024 and 2023:


	Three months ended October 31,
	2024		2023
Segment profit:
Americas & Asia	$	54,900	$	49,897
Europe & Australia	13,114		16,744
Total Company	$	68,014	$	66,641

Reconciliation of Segment Profit

The following is a reconciliation of segment profit to income before income taxes for the three months ended October 31, 2024 and 2023:


	Three months ended October 31,
	2024		2023
Total profit from reportable segments	$	68,014	$	66,641
Unallocated amounts:
Administrative costs	(9,092)		(6,911)
Investment and other income	1,234		438
Interest expense	(1,356)		(766)
Income before income taxes	$	58,800	$	59,402

Stock-Based Compensation (Tables)

3 Months Ended

Oct. 31, 2024

Stockholders' Equity Note [Abstract]

Schedule of Stock Option Activity

The following is a summary of stock option activity for the three months ended October 31, 2024:


Time-Based Options	Options Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at July 31, 2024	1,222,046	$	44.46
Granted	—	—
Exercised	(128,803)	38.83
Forfeited	(1,720)	50.19
Outstanding at October 31, 2024	1,091,523	$	45.12	5.4	$	28,592
Exercisable at October 31, 2024	1,010,597	$	44.84	5.2	$	26,754

The following table summarizes additional stock option information:


	Three months ended October 31,
	2024		2023

Intrinsic value of options exercised during the period (in thousands)	$	4,622	$	3,410
Fair value of options vested during the period (in thousands)	1,249		1,729
Cash received from the exercise of stock options during the period (in thousands)	5,855		2,598
Tax benefit on options exercised during the period (in thousands)	1,112		841

Schedule of RSU Activity

The following is a summary of RSU activity for the three months ended October 31, 2024:


	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested RSUs as of July 31, 2024	148,991	$	52.20
Granted	88,319	74.63
Vested	(56,393)	51.07
Forfeited	(763)	58.94
Non-vested RSUs as of October 31, 2024	180,154	$	63.53

Schedule of PRSU Activity

The following is a summary of PRSU activity for the three months ended October 31, 2024:


	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested PRSUs as of July 31, 2024	103,221	$	53.46
Granted	61,981	71.24
Vested	(8,098)	64.44
Forfeited	(2,157)	55.23
Non-vested PRSUs as of October 31, 2024	154,947	$	59.95

Net Income per Common Share (Tables)

3 Months Ended

Oct. 31, 2024

Earnings Per Share [Abstract]

Schedule of the Reconciliation for the Numerator and Denominator of Basic and Diluted Per Share

Reconciliations of the numerator and denominator of the basic and diluted per share computations for the Company’s Class A and Class B common stock are summarized as follows:


	Three months ended October 31,
	2024		2023
Numerator (in thousands):
Net income (Numerator for basic and diluted income per Class A Nonvoting Common Share)	$	46,783	$	47,241
Less:
Preferential dividends	(736)		(748)
Preferential dividends on dilutive stock options	(8)		(5)
Numerator for basic and diluted income per Class B Voting Common Share	$	46,039	$	46,488
Denominator (in thousands):
Denominator for basic income per share for both Class A and Class B	47,732		48,505
Plus: Effect of dilutive equity awards	485		306
Denominator for diluted income per share for both Class A and Class B	48,217		48,811
Net income per Class A Nonvoting Common Share:
Basic	$	0.98	$	0.97
Diluted	$	0.97	$	0.97
Net income per Class B Voting Common Share:
Basic	$	0.96	$	0.96
Diluted	$	0.95	$	0.95

Fair Value Measurements (Tables)

3 Months Ended

Oct. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Financial Assets and Liabilities Accounted for at Fair Value on a Recurring Basis

The following table summarizes the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis at October 31, 2024 and July 31, 2024:


	October 31, 2024		July 31, 2024		Fair Value Hierarchy
Assets:
Deferred compensation plan assets	$	18,180	$	20,029	Level 1
Foreign exchange contracts	148		137		Level 2
Liabilities:
Foreign exchange contracts	1,614		730		Level 2

Derivatives and Hedging Activities (Tables)

3 Months Ended

Oct. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Notional Amounts of Outstanding Forward Exchange Contracts

The U.S. dollar equivalent notional amounts of outstanding forward exchange contracts were as follows:


	October 31, 2024		July 31, 2024
Designated as cash flow hedges	$	44,448	$	59,207
Non-designated hedges	4,171		4,459
Total foreign exchange contracts	$	48,619	$	63,666

Schedule of Derivative Instruments, Effect on Other Comprehensive Loss

The following table summarizes the amount of pre-tax gains and losses related to derivatives designated as hedging instruments:


	Three months ended October 31,
	2024		2023
(Losses) gains recognized in OCI:
Forward exchange contracts (cash flow hedges)	$	(1,338)	$	(294)
Foreign currency denominated debt (net investment hedges)	(190)		1,508
Gains reclassified from OCI into cost of goods sold:
Forward exchange contracts (cash flow hedges)	464		1,285

Schedule of Fair Values of Derivative Instruments in the Condensed Consolidated Balance Sheets

Fair values of derivative instruments in the condensed consolidated balance sheets were as follows:


	October 31, 2024						July 31, 2024
	Prepaid expenses and other current assets		Other current liabilities		Long-term Obligations		Prepaid expenses and other current assets		Other current liabilities		Long-term Obligations
Derivatives designated as hedging instruments:
Foreign exchange contracts (cash flow hedges)	$	148	$	1,610	$	—	$	137	$	726	$	—
Foreign currency denominated debt (net investment hedges)	—		—		34,251		—		—		34,060
Derivatives not designated as hedging instruments:
Foreign exchange contracts (non-designated hedges)	—		4		—		—		4		—
Total derivative instruments	$	148	$	1,614	$	34,251	$	137	$	730	$	34,060

Acquisition (Tables)

3 Months Ended

Oct. 31, 2024

Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The following table summarizes the preliminary fair value of the assets acquired and liabilities assumed at the date of the acquisition:


Cash and cash equivalents	$	7,667
Accounts receivable, net	24,325
Inventories	21,751
Prepaid expenses and other current assets	563
Property, plant and equipment — net	2,538
Goodwill	71,790
Other intangible assets	65,798
Operating lease assets	6,981
Other assets	1,061
Accounts payable	(17,813)
Accrued compensation and benefits	(9,347)
Taxes, other than income taxes	(6,857)
Accrued income taxes	(1,855)
Other current liabilities	(18,157)
Operating lease liabilities	(6,980)
Other liabilities	(6,908)
Net assets acquired	$	134,557
Less: cash acquired	(7,667)

Fair value of total consideration	$	126,890

Business Acquisition, Pro Forma Information


	Three months ended October 31,
	2024		2023
Net sales, pro forma	$	377,065	$	361,109
Net income, pro forma	46,783		43,535

Additional Balance Sheet Disclosures - (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Inventory Disclosure [Abstract]
Finished products	$ 103,375	$ 89,430
Work-in-process	27,029	24,601
Raw materials and supplies	48,284	38,698
Total inventories	178,688	152,729
Property, Plant and Equipment, Gross [Abstract]
Accumulated Depreciation of PPE	$ (308,128)	$ (304,199)

Other Intangible Assets (Detail) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Other Intangible Assets [Line Items]
Intangible Assets, Gross (Excluding Goodwill)	$ 150,591	$ 81,900
Accumulated Amortization	(34,222)	(30,061)
Net Book Value	116,369	51,839
Indefinite-lived Intangible Assets (Excluding Goodwill)	$ 7,577	$ 7,570
Tradenames [Member]
Other Intangible Assets [Line Items]
Weighted Average Amortization Period	2 years	3 years
Finite-Lived Intangible Assets, Gross	$ 868	$ 600
Accumulated Amortization	(108)	(600)
Finite-Lived Intangible Assets, Net	$ 760	$ 0
Customer Relationships [Member]
Other Intangible Assets [Line Items]
Weighted Average Amortization Period	8 years	9 years
Finite-Lived Intangible Assets, Gross	$ 122,289	$ 64,430
Accumulated Amortization	(26,899)	(23,279)
Finite-Lived Intangible Assets, Net	$ 95,390	$ 41,151
Technology [Member]
Other Intangible Assets [Line Items]
Weighted Average Amortization Period	5 years	5 years
Finite-Lived Intangible Assets, Gross	$ 19,857	$ 9,300
Accumulated Amortization	(7,215)	(6,182)
Finite-Lived Intangible Assets, Net	$ 12,642	$ 3,118

Intangible Assets - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of Intangible Assets	$ 4,713	$ 2,355

Leases (Details) - USD ($) $ in Thousands	3 Months Ended
Leases (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 31, 2023
Leases [Abstract]
Operating Lease, Cost	$ 4,735	$ 4,065
Operating cash flows from operating leases	4,619	4,431
Operating lease assets obtained in exchange for new operating lease liabilities (1)	$ 7,630	$ 1,656

Accumulated Other Comprehensive Loss, Net of Tax (Detail) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	$ (109,622)	$ (93,061)
Other comprehensive loss before reclassification	(1,481)	(21,108)
Amounts reclassified from accumulated other comprehensive loss	(499)	(1,114)
Ending balance	(111,602)	(115,283)
Unrealized loss on cash flow hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(149)	1,641
Other comprehensive loss before reclassification	(1,402)	(744)
Amounts reclassified from accumulated other comprehensive loss	(348)	(963)
Ending balance	(1,899)	(66)
Unamortized gain on post-retirement plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	462	756
Other comprehensive loss before reclassification	0	0
Amounts reclassified from accumulated other comprehensive loss	(151)	(151)
Ending balance	311	605
Foreign currency translation adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(109,935)	(95,458)
Other comprehensive loss before reclassification	(79)	(20,364)
Amounts reclassified from accumulated other comprehensive loss	0	0
Ending balance	$ (110,014)	$ (115,822)

Accumulated Other Comprehensive Income, Tax (Detail) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Other Comprehensive Income (Loss), Tax [Abstract]
Cash flow hedges	$ 52	$ (128)

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended
Revenue Recognition (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 31, 2023	Jul. 31, 2024
Revenue Recognition [Abstract]
Contract with Customer, Liability	$ 2,973		$ 2,947
Deferred Revenue, Revenue Recognized	$ 337	$ 314
Remaining Performance Obligations Expected as Revenue During the Remainder of the Current Fiscal Year	32.00%
Remaining Performance Obligations Expected as Revenue Over the Next Full Fiscal Year	31.00%

Segment Information - Schedule of Segment Reporting Information By Segment (Detail) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Segment Reporting Information [Line Items]
Net sales	$ 377,065	$ 331,983
Segment Profit	68,014	66,641
Americas & Asia
Segment Reporting Information [Line Items]
Net sales	245,428	221,626
Segment Profit	54,900	49,897
Europe & Australia
Segment Reporting Information [Line Items]
Net sales	131,637	110,357
Segment Profit	13,114	16,744
Americas \| Americas & Asia
Segment Reporting Information [Line Items]
Net sales	214,033	196,286
Asia \| Americas & Asia
Segment Reporting Information [Line Items]
Net sales	31,395	25,340
Europe \| Europe & Australia
Segment Reporting Information [Line Items]
Net sales	116,153	96,333
Australia \| Europe & Australia
Segment Reporting Information [Line Items]
Net sales	$ 15,484	$ 14,024

Segment Information - Net Income Reconciliation (Detail) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Segment Reconciliation [Abstract]
Total profit from reportable segments	$ 68,014	$ 66,641
Unallocated amounts:
Administrative costs	(9,092)	(6,911)
Investment and other income	1,234	438
Interest expense	(1,356)	(766)
Income before income taxes	$ 58,800	$ 59,402

Stock Based Compensation - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 5,813	$ 4,163
Share-based Payment Arrangement, Expense, Tax Benefit	632	$ 425
Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrealized compensation cost related to share-based compensation, pre tax	$ 674
Weighted average period remaining	1 year 6 months
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrealized compensation cost related to share-based compensation, pre tax	$ 6,090
Weighted average period remaining	2 years 4 months 24 days
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrealized compensation cost related to share-based compensation, pre tax	$ 6,812
Weighted average period remaining	2 years 3 months 18 days
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years

Stock-Based Compensation Stock Options Outstanding (Details)	3 Months Ended
	Oct. 31, 2024 shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Options Outstanding, Beginning Balance	1,222,046
Options, Grants in Period	0
Options, Exercised in Period	(128,803)
Options, Forfeited or expired in Period	1,720
Options Outstanding, Ending Balance	1,091,523
Options Exercisable	1,010,597

Stock-Based Compensation Stock Options Weighted Average Exercise Price (Details)	3 Months Ended
	Oct. 31, 2024 $ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options Outstanding, Beginning Balance, Weighted Average Exercise Price	$ 44.46
Options, Grants in Period, Weighted Average Exercise Price	0
Options, Exercises in Period, Weighted Average Exercise Price	38.83
Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price	50.19
Options Outstanding, Ending Balance, Weighted Average Exercise Price	45.12
Options Exercisable, Weighted Average Exercise Price	$ 44.84

Stock-Based Compensation Stock Options - Additional Disclosures (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Weighted Average Remaining Contractual Term	5 years 4 months 24 days
Options Exercisable, Weighted Average Remaining Contractual Term	5 years 2 months 12 days
Options, Outstanding, Intrinsic Value	$ 28,592
Options, Exercisable, Intrinsic Value	26,754
Proceeds from exercise of stock options	5,855	$ 2,598
Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, Exercises in Period, Intrinsic Value	4,622	3,410
Fair value of options vested	1,249	1,729
Proceeds from exercise of stock options	5,855	2,598
Share-based Payment Arrangement, Exercise of Option, Tax Benefit	$ 1,112	$ 841

Stock-Based Compensation - Summary of RSU and PRSU Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-vested as of July 31, 2023	148,991
Equity Instruments Other than Options, Grants in Period	88,319
Equity Instruments Other than Options, Vested in Period	(56,393)
Equity Instruments Other than Options, Forfeited in Period	(763)
Non-vested as of October 31, 2023	180,154
Non-vested as of July 31, 2023, Weighted Average Grant Date Fair Value	$ 52.20
Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	74.63	$ 54.80
Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	51.07
Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	58.94
Non-vested as of October 31, 2023, Weighted Average Grant Date Fair Value	$ 63.53
Equity Instruments Other than Options, Vested in Period, Fair Value	$ 4,201	$ 2,974
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-vested as of July 31, 2023	103,221
Equity Instruments Other than Options, Grants in Period	61,981
Equity Instruments Other than Options, Vested in Period	(8,098)
Equity Instruments Other than Options, Forfeited in Period	(2,157)
Non-vested as of October 31, 2023	154,947
Non-vested as of July 31, 2023, Weighted Average Grant Date Fair Value	$ 53.46
Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	71.24	$ 51.16
Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	64.44
Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	55.23
Non-vested as of October 31, 2023, Weighted Average Grant Date Fair Value	$ 59.95
Equity Instruments Other than Options, Vested in Period, Fair Value	$ 595	$ 141

Net Income per Common Share - Reconciliation of Numerator and Denominator of Basic and Diluted Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Earnings Per Share [Line Items]
Net income	$ 46,783	$ 47,241
Denominator for basic income per share for both Class A and Class B	47,732	48,505
Plus: Effect of dilutive equity awards	485	306
Denominator for diluted income per share for both Class A and Class B	48,217	48,811
Class A Nonvoting Common Stock
Earnings Per Share [Line Items]
Basic	$ 0.98	$ 0.97
Diluted	$ 0.97	$ 0.97
Class B Voting Common Stock
Earnings Per Share [Line Items]
Preferential dividends	$ (736)	$ (748)
Preferential dividends on dilutive stock options	(8)	(5)
Numerator for basic and diluted income per Class B Voting Common Share	$ 46,039	$ 46,488
Basic	$ 0.96	$ 0.96
Diluted	$ 0.95	$ 0.95

Net Income per Common Share - Additional Information (Detail) - shares	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Earnings Per Share [Abstract]
Anti-dilutive Shares	17,278	313,787

Fair Value Measurements - Financial Assets and Liabilities Accounted for at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Fair Value, Inputs, Level 1 [Member] \| Other Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation plan assets	$ 18,180	$ 20,029
Fair Value, Inputs, Level 2 [Member] \| Prepaid expenses and other current assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign exchange contracts	148	137
Fair Value, Inputs, Level 2 [Member] \| Other current liabilities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign exchange contracts	$ 1,614	$ 730

Derivatives and Hedging Activities Notional Amount of Derivative Contracts (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Derivative [Line Items]
Derivative, Notional Amount	$ 48,619	$ 63,666
Designated as hedging instruments [Member]
Derivative [Line Items]
Derivative, Notional Amount	44,448	59,207
Not designated as hedging Instruments [Member
Derivative [Line Items]
Derivative, Notional Amount	$ 4,171	$ 4,459

Derivative Instruments and Hedging Activities Pre-Tax Gains and Losses related to Foreign Exchange Contracts (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Net loss recognized in other comprehensive loss	$ (1,338)	$ (294)
Foreign currency denominated debt (net investment hedges)	(190)	1,508
Forward exchange contracts (cash flow hedges)	$ 464	$ 1,285

Derivatives and Hedging Activities - Fair Values of Derivative Instruments in Consolidated Balance Sheets (Detail) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024
Prepaid expenses and other current assets [Member]
Derivatives, Fair Value [Line Items]
Derivatives Assets	$ 148	$ 137
Other current liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivatives Liabilities	$ 1,614	$ 730
Foreign Line of Credit
Derivatives, Fair Value [Line Items]
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other Long-Term Debt, Noncurrent	Other Long-Term Debt, Noncurrent
Designated as hedging instruments [Member] \| Prepaid expenses and other current assets [Member] \| Foreign Exchange Contract \| Cash Flow Hedging [Member]
Derivatives, Fair Value [Line Items]
Derivatives Assets	$ 148	$ 137
Designated as hedging instruments [Member] \| Other current liabilities [Member] \| Foreign Exchange Contract \| Cash Flow Hedging [Member]
Derivatives, Fair Value [Line Items]
Derivatives Liabilities	$ 1,610	$ 726
Designated as hedging instruments [Member] \| Foreign Line of Credit \| Net Investment Hedging [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other Long-Term Debt, Noncurrent	Other Long-Term Debt, Noncurrent
Not designated as hedging Instruments [Member \| Prepaid expenses and other current assets [Member] \| Foreign Exchange Contract \| Cash Flow Hedging [Member]
Derivatives, Fair Value [Line Items]
Derivatives Assets	$ 0	$ 0
Not designated as hedging Instruments [Member \| Other current liabilities [Member] \| Foreign Exchange Contract \| Cash Flow Hedging [Member]
Derivatives, Fair Value [Line Items]
Derivatives Liabilities	$ 4	$ 4

Derivatives and Hedging Activities - Additional Information (Detail) - USD ($) $ in Thousands	Oct. 31, 2024	Jul. 31, 2024	Oct. 31, 2023	Jul. 31, 2023
Derivative [Line Items]
Derivative maturity	18 months
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	$ (1,926)	$ 124
Accumulated other comprehensive loss	(111,602)	(109,622)	$ (115,283)	$ (93,061)
Net Investment Hedging [Member]
Derivative [Line Items]
Accumulated other comprehensive loss	$ (1,427)	$ (1,237)

Income Taxes Effective Income Tax Rate (Details)	3 Months Ended
Income Taxes Effective Income Tax Rate (Details)	Oct. 31, 2024 Rate	Oct. 31, 2023 Rate
Income Tax Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, Percent	20.40%	20.50%

Business Combinations, Descriptions (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 01, 2024	Aug. 01, 2024	Jul. 31, 2024
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired	$ 140,625	$ 0
Goodwill	$ 671,705				$ 589,611
Gravotech Acquisition
Business Acquisition [Line Items]
Business Acquisition, Name of Acquired Entity	Gravotech
Business Acquisition, Effective Date of Acquisition	Aug. 01, 2024
Business Acquisition, Description of Acquired Entity	Headquartered in Lyon, France, Gravotech is a leader in the design, manufacture and distribution of innovative solutions for specialized engraving, marking and cutting, offering laser, mechanical engraving, scribing and dot peen capabilities across multiple industries. The acquisition of Gravotech expands the Company’s identification product offerings and research and development capabilities to include specialized direct part marking and engraving expertise.
Goodwill				$ 71,790
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Assets				$ 6,981
AB&R
Business Acquisition [Line Items]
Business Acquisition, Name of Acquired Entity	AB&R
Business Acquisition, Effective Date of Acquisition	Oct. 01, 2024
Business Combination, Reason for Business Combination	Based in Phoenix, Arizona, AB&R provides integrated solutions for asset tracking, inventory management, and workflow optimization using advanced identification and tracking technologies, including barcoding, radio frequency identification (“RFID”) and Internet of Things (“IoT”)-based systems.
Payments to Acquire Businesses, Net of Cash Acquired	$ 15,625
Business Acquisition, Goodwill, Expected Tax Deductible Amount			$ 10,877
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets			4,600
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Assets			$ 148
Business Combination, Acquisition Related Costs	$ 305

Acquisition Fair Values of the Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 01, 2024	Aug. 01, 2024	Jul. 31, 2024
Business Acquisition [Line Items]
Goodwill	$ 671,705			$ 589,611
Gravotech Acquisition
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents			$ (7,667)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables			24,325
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory			21,751
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets			563
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment [Abstract]			2,538
Goodwill			71,790
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			65,798
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Assets			6,981
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets			1,061
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable			(17,813)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Compensation and Benefits			(9,347)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Taxes other than income taxes			(6,857)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities			(1,855)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other			(18,157)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Obligation			(6,980)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other			(6,908)
Business Combination, Recognized Identifiable Assets Acquired Including Cash and Liabilities Assumed, Net			134,557
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net			126,890
Gravotech Acquisition \| Americas & Asia
Business Acquisition [Line Items]
Goodwill			49,874
Gravotech Acquisition \| Europe & Australia
Business Acquisition [Line Items]
Goodwill			$ 21,916
AB&R
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Assets		$ 148
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets		4,600
AB&R \| Americas & Asia
Business Acquisition [Line Items]
Goodwill		$ 10,877

Business Combinations, Pro Forma Information, Gravotech (Details) - Gravotech Acquisition - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Business Acquisition, Pro Forma Revenue	$ 377,065	$ 361,109
Business Acquisition, Pro Forma Net Income (Loss)	46,783	$ 43,535
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual	29,475
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual	$ 4,685

Acquisition - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 01, 2024	Aug. 01, 2024	Jul. 31, 2024
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired	$ 140,625	$ 0
Goodwill	671,705				$ 589,611
Gravotech Acquisition
Business Acquisition [Line Items]
Goodwill				$ 71,790
Amortization	2,326
Gravotech Acquisition \| Americas & Asia
Business Acquisition [Line Items]
Goodwill				$ 49,874
Gravotech Acquisition \| Fair Value Adjustment to Inventory
Business Acquisition [Line Items]
Cumulative expenses, net of tax, adjusted in pro forma	(4,115)
AB&R
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired	15,625
Business Combination, Acquisition Related Costs	$ 305
Business Acquisition, Goodwill, Expected Tax Deductible Amount			$ 10,877
AB&R \| Americas & Asia
Business Acquisition [Line Items]
Goodwill			$ 10,877